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INTRODUCTION
The Safe Medicine Disposal for ME (SMDME) program is a statewide model for the
disposal of unused household medications using a mail-back return envelope system.
Established through state legislation and implemented in 2007 with a grant from the
U.S. Environmental Protection Program’s Aging Initiative, the program is authorized to
handle both controlled and non-controlled medications (see appendix group 4 for
historical documents related to the program). This handbook describes the program
components, as well as the outcomes and lessons learned from Phases I & II of the
program. The handbook is designed as a guide to organizations that are implementing
similar programs in other states.

Maine, which has a combination of rural regions and urban centers, serves as an ideal
state in which to test distribution and collection methods, combined with cost
containment. The pilot program began with 11 participating pharmacies, and has since
expanded to include approximately 150 pharmacies and health and human services
agencies in all 16 counties of Maine. The program has broadened from the original
target audience of older adults and caregivers to include adults of all ages. The program
currently maintains a waiting list of interested community-based distribution sites.

The mail-back program, during its first two phases of operation, has disposed of more
than 2,300 lbs of drugs, representing 3,926 envelopes. Pharmacist and pharmacy tech
volunteers have cataloged and inventoried those envelopes through eight cataloging
events during the first two phases of the program. The volume was so great that the
inventory method was changed to a 20% sampling process during the second year of
operation.
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Why Collect Unused Pharmaceuticals?
The Athens Declaration,1 developed in 2007 at the 2nd International Conference on the
Environment in Athens, Greece, supported six reasons for citizens to tackle unused
drug disposal: (1) to curtail childhood overdoses; (2) to restrict household drug theft; (3)
to limit accumulation of drugs by the elderly; (4) to protect our physical environment; (5)
to restrain improper international drug donations; and (6) to eliminate waste in the
international health care systems of all
The Athens Declaration
(see appendix)
Rationale for citizen unused drug disposal
•
•
•
•
•
•

countries.

Any or all of the Athens Declaration reasons
could be adopted as program goals for a

To curtail childhood overdoses
To restrict household drug theft
To limit accumulation of drugs by the
elderly
To protect our physical environment
To restrain improper international
drug donations
To eliminate waste in the international
health care systems of all countries

mail-back drug return program. Goals
should state in general terms what the
program aims are, and what impact you
hope to have. The Athens Declaration
components describe a hoped-for result,
but state it in a general (not objectified)
fashion.

The Pharmaceutical Manufacturers’ Association estimates that more than 3.6 billion
prescriptions are written each year in the United States.2 More recent figures indicate
that U.S. sales of prescription medicines rose 5.1 percent in 2009 to $300.3 billion.3 In
Maine, more than 16 million prescriptions were filled in 2008,4 including 2.3 million

1 The Athens Declaration can be found at http://www.mainebenzo.org/athensdeclaration.htm. The Declaration refers
to two World Health Organization documents, the WHO Guidelines on Drug Donations and the WHO Guidelines on
Drug Disposal, which are also referenced at this web address.
2 Pharmaceutical Manufacturers Association, Frequently Asked Questions, accessed December 21, 2009,
(http://www.phrma.org/frequently_asked_questions)
3 The Star-Ledger, Prescription drug sales rise 5.1 percent in 2009, accessed April 2, 2010,
(http://www.nj.com/business/index.ssf/2010/04/prescription_drug_sales_rise_5.html)
4 United States: Prescription Drugs, Compare United States to Maine, accessed December 21, 2009
(http://www.statehealthfacts.org/profileind.jsp?cmprgn=21&cat+5&rgn=1&sub=66)
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prescriptions for controlled drugs,5 or 157 million dosage units. Yet, research indicates
that patients very frequently do not take prescribed medications as they were directed, if
at all.6,7

Yet, research indicates that patients very frequently do not take
prescribed medications as they were directed, if at all.

In Maine, diverted, abused, and misused prescription drugs are a major cause of
accidental poisonings and arrests. In 2008, 95% of Maine drug deaths were caused
by pharmaceutical drugs, either alone or in combination with other drugs.8 The state
has seen arrest rates for prescription drug-related offenses rise from 50 in 1998 to 75 in
2003, and 259 (39% of all arrests) in 2008.9 According to data from the 2008 National
Drug Intelligence Center’s National Drug Threat Survey, the state of Maine ranks
number one in the country in terms of the perceived relationship of pharmaceuticals to
violent crime and property crime, and second in terms of the availability of
pharmaceuticals for abuse. Forty percent of Maine law enforcement agencies perceive
prescription drug misuse as the most serious drug threat.10

Medication safety affects all ages. For youth, one of the fastest growing trends
nationally in teenage prescription drug abuse is the “pharm party” where teens dump
bottles of prescription medications they have found into a punch bowl to be distributed
like candy. According to results from the 2006 Maine Youth Drug and Alcohol Use
(MYDAUS) Survey, 12% of teenagers in grades 6 through 12 across the state report

Maine Prescription Monitoring Program, “PMP Prescription Count Trends within Counties,”
(http:///www.maine.gov/dhhs/osa/data/pmp/reports.htm), accessed December 21, 2009.
6 Sabate, E. (ed.) Adherence to Long Term Therapies: Evidence for Action. World Health Organization. Geneva,
2003.
7 Osterberg, L and T. Blaschke, “Adherence to medication,” New England Journal of Medicine 353:487-97, 2005.
8 Personal communication, MH Sorg, Rural Drug and Alcohol Research Program, Margaret Chase Smith Policy Center,
University of Maine.
9 Sorg, MH (forthcoming) Patterns and Trends of Drug Abuse in Maine. In Epidemiologic Trends in Drug Abuse:
Proceedings of the Community Epidemiology Work Group, June 2009. National Institute on Drug Abuse.
10 Testimony presented at the Hearing on HP0557, LD 821, An Act To Support Collection and Proper Disposal of
Unwanted Drugs, April 14, 2009.
5
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experimenting with prescription drugs, and 1 in 5 Maine youth in grades 9-12 report
having used a prescription drug not prescribed to them to get high.

For older adults, persons 65 and older represent 13% of the U.S. population yet
consume about a third of prescriptions sold.11 Older patients also have the lowest
prescription drug compliance rates of any age, including never filling their prescription,
filling but not taking the prescription, taking only part of the doses, or taking less than
the prescribed dose.12 These behaviors occur in all age groups, not just elders, and
result in an accumulation of medications in the household.

The large, accumulating volume of unused pharmaceuticals not only poses potential
dangers to communities and to the environment,13 it also represents a significant overexpenditure of health care dollars. Pharmaceutical drug residues have been found in
many environmental contexts, including our sewer systems and our drinking water.14 In
a recent study by the Maine Department of Environmental Protection (MDEP),
pharmaceuticals and personal care products (PPCPs) were found in 18 out of 19
samples of Maine water samples,15 with a majority of sites having three or more types of
PPCPs present.

Although research clearly shows the presence of pharmaceuticals and other personal
care products in our water supply, the effects of these exposures on the environment
will depend on many factors, including the specific chemicals involved and the variation
in their effects on different organisms. One topic that is of concern to some scientists is
the impact on reproduction processes.
Prescription Drug Abuse Statistics. www.prescriptiondrugabuse.us/statistics-facts.html, accessed December 21,
2009.
12 Kocurek, B., “Promoting medication adherence in older adults…and the rest of us. Diabetes Spectrum 22:80-84,
2008.
13 Daughton, C. “Drug disposal: Ramifications for the environment and human health.” U.S. Environmental Protection
Agency, Drug Disposal, Pharmaceutical and Personal Care Products.
(http://www.epa.gov/ppcp/projects/disposal.html), accessed December 21, 2009.
14 Ruhoy, I.S. and C.G. Daughton, “Types and quantities of leftover drugs entering the environment via disposal to
Sewage-Revealed by coroner records,” Sci. Total Environ. 388(1-3):137-148, 2007, also available at
(http://www.epa.gov/newlesd1/bios/daughton/SOTE2007.pdf)
11

15 Littell, D.P. (2007) “Waste Pharmaceuticals: The Road Forward,” Maine DEP. Conference Presentation, Improving
Patient Safety through Informed Medication Prescribing and Disposal Practices, Fourth Annual Unused Drug Return
Conference, (http://www.mainebenzo.org/documents/WastePharmaceuticalOct07_001.pdf).

Safe Medicine Disposal for ME: A Handbook and Summary Report y April 2010

9

More research is needed to clarify both the short term and long term impacts on
humans. In addition, research is needed to document the costs and benefits of various
interventions. This project contributes to the ongoing discussion.

What Is The Best Way To Dispose Of Medicines?
Several basic methods are currently being used in the United States to dispose of
unused medicines: flushing, throwing away and collecting. These approaches are
reviewed in the Appendix in a document prepared by the Northern New England Poison
Center (see the Medication Disposal Summary Report in Appendix Group 4). Opinions
about the best method for drug disposal vary widely. Benefits and costs of each
method are different, and state legislatures have addressed these issues in different
ways. The most important goals that concerned citizens and legislatures focus on are
(1) preventing poisoning, (2) preventing drug abuse, (3) ensuring the safety of patients,
and (4) limiting environmental impacts.

The method described in this handbook
involves a statewide effort to collect drugs
using a mail-back system, followed by high
temperature incineration. This method has
the advantages of preventing unintentional
poisonings, preventing access to medicines

Medication Disposal Goals
1. Prevent poisoning
2. Prevent drug diversion &
abuse
3. Ensure patient safety
4. Limit environmental
damage

by drug abusers, and limiting impact on the
environment. It is not as immediately inexpensive to the community, or as convenient,
as throwing away or flushing. However, throwing away and flushing may create long
term environmental costs that communities may have to bear in the future.

The mail-back mechanism has the advantage of being continuously available to
community members. Compared to event-type community take-backs, the mail-back
program does not contribute to hording medicines between take-back events, which
might set the stage for diversion or poisonings.
Safe Medicine Disposal for ME: A Handbook and Summary Report y April 2010
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Mail-back programs incur immediate costs, involve substantial program management,
and still require law enforcement collaboration as do other models. These costs should
be balanced against the estimated costs of future environmental damage, as well as the
societal costs of drug diversion and poisoning.

An additional cost factor to consider is the drug waste within our medical system.
Medication accumulates in households because too much, or the wrong drug was
prescribed; patients did not take the drugs, or did not take them as directed. These
effects point to the importance of careful prescription management and patient
education at the front end.

How to Use This Handbook
This handbook was produced as a general guide to organizations interested in
developing a mail-back program in their state, region, corporate or affinity group. It is
not meant as a step-by-step manual. Each state’s laws and cultural context are unique.
For example, responses and participation by particular stakeholders, such as law
enforcement agencies, will vary greatly. Additionally, ideas about prescription drug
return programs will have evolved since work began on this project two years ago.
There must be recognition that Federal law and regulations has played a major role in
shaping, and at times constraining, certain aspects of the mailback program design.

Thus, we have provided an overview of the principles and guidelines to serve as a
concept umbrella. Readers will find more specific material in the appendices. These
documents may be of assistance as new programs are developed and the guidelines
are being implemented.
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Helpful Appendices Included:
•
•
•
•
•
•
•
•

Contact information for program leadership
Organizations (state, federal, national, and international) that were involved, to
provide ideas about stakeholders to include
A detailed project conceptual timeline to assist in planning
Legal and technical documents and agreements that link the project with
multiple stakeholders
Sample distribution site materials
Helpline and volunteer information
Instruction booklet for preparing and returning medicine
Marketing and outreach materials
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BUILDING A SOLID FOUNDATION

“A major reason we went with a mail‐back program is that we’re the third
most rural state in the nation, our population is very dispersed, and we have
a significant prescription drug problem. We believed mail‐back
programming might be the most convenient and the least cumbersome
method to use. We not only considered rurality issues, but also considered
the vulnerability of populations who are less mobile, and less physically able
to transport medications from one point to another.”
Lenard Kaye, D.S.W, Ph.D, Director and Professor,
University of Maine Center on Aging

Engaging Stakeholders: Community, Academic, and Government
By the time the proposal to pilot the Maine mail-back program was written in 2007, a
wide range of stakeholders had been engaged for several years in discussions with
policy makers about Maine’s prescription drug problem generally. A coalition, initially
convened by the Maine Benzodiazepine Study Group (MBSG) and the Maine Drug
Enforcement Agency (MDEA), began to consider drug return programs as one solution
beginning in 2002.

Stakeholders were included in these discussions from children’s advocacy, substance
abuse treatment, law enforcement, environmental organizations, medical associations,
university research programs, as well as legislators and other policy makers. Every
effort was made to come to informal consensus as the work proceeded. Communication
with Federal agencies was initiated early on in the process for general guidance and to
ensure clarification of existing regulations.
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Detailed discussions and presentations of research clarified the costs and benefits of
various drug disposal approaches that had been tried, and highlighted some of the
program issues to be faced by the Maine program. These efforts ultimately stimulated
the passage by State Legislation of Public Law 2003, Chapter 679, which formed the
Maine Unused Pharmaceutical Disposal Program, and created the Maine Drug Return
Implementation Group. This work group came to consensus that a mail-back approach
would work best in Maine.

Meeting the Challenges of a Rural and Aging State
Maine ranks 38th in population density nationwide with fewer than 10 residents per
square mile in over half of the state. This poses challenges to distribution and collection
methods as well as financial challenges. Maine also has the oldest population in the
country with a median age of 41.2 years (United States Census, 2005). Needing to
travel long distances to bring unused drugs to a collection site would have posed
problems for a substantial number of Maine’s elders. Using the U.S. Postal Service
system solves that problem because virtually all of Maine’s citizens have access to the
mail.

Selecting an Environmentally Sound and Legally Secure System
In addition to the issues involved in securing and transporting drugs over long
distances, there was controversy about the best way to dispose of them. Program
leaders were aware of the research about the environmental hazards posed by drugs
getting into the groundwater, either through flushing or solid waste disposal. Although
the financial costs and impact on air quality were also certainly important factors,
incineration was ultimately chosen as the method of disposal for the mailback program
as it would minimize environmental impact. All drugs collected undergo high-heat
incineration, according to the procedure already established for Maine’s law
enforcement drug seizures.

Incineration avoids the problems of direct contamination of water. The MDEA had been
using this method to dispose of drugs from law enforcement seizures. The form of
Safe Medicine Disposal for ME: A Handbook and Summary Report y April 2010
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incineration already in use by the MDEA was a controlled, high-heat process designed
to convert waste to energy. (See Appendix 4E for a breakdown of other drug collection
methods with their advantages and disadvantages.)

Political Will and Partnerships
Issues surrounding the collection and disposal of pharmaceuticals involve many
professional, legal, and regulatory agencies. For this reason any proposed project
should be founded upon an extensive network of professional and community
partnerships. Development of these working relationships took several years prior to
actual implementation of the Maine program and involved each of those acknowledged
at the beginning of this handbook.

Key project partners within Maine included the Maine Benzodiazepine Study Group, the
Maine Department of Environmental Protection, the Maine Drug Enforcement Agency,
the Maine Office of Substance Abuse, the Maine Department of Health, the Maine
Office of the Attorney General, the U.S. District Attorney for Maine, and the University of
Maine Center on Aging. A technical expert advisory task force was formed that included
members from each of these and a cadre of partnering organizations. The Community
Advisory Group (explained in more detail later) provided a critical consumer
perspective, including the perspectives of individuals involved “at the front line:” the
project volunteers handling community education and marketing.

The Maine Department of Health and Human Services and the Maine Department of
Environmental Protection both provided assistance with public education and outreach
in Phase I and II, and a representative from each group acted as their organization’s
liaison to the project.

A number of state and national specialists and associations also committed to the
project. Both the Community Medical Foundation for Patient Safety and the National
Council on Patient Information and Education agreed to enlist their staff to review
instructions and informational materials to be distributed to distributions sites and mailSafe Medicine Disposal for ME: A Handbook and Summary Report y April 2010
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back participants. Rite Aid Corporation, the nation’s third largest drugstore chain and
the largest on the east coast, formally committed to participation in the pilot project with
their pharmacies serving as distribution site locations.

Researchers from the University of Maine Margaret Chase Smith Policy Center
committed to project evaluation and to act as an outside advisor to the project on
matters related to drug disposal.

In Maine, there has also been a key legislative component to coalition building. In 2003,
the Maine Benzodiazepine Study Group and the Maine Drug Enforcement Agency
convened a group of stakeholders from various sectors and professions including
children’s advocacy, environmental and medical organizations, and higher education
research units. The Center on Aging at the University of Maine assumed the
administrative coordination of the project. The group’s focus was to create legislative
solutions to the problem of diversion, misuse and abuse of prescription drug
medications.
A legislative mandate, Public Law 2003, Chapter 679,16 created the Maine Unused
Pharmaceutical Disposal Program and tasked the Maine Drug Enforcement Agency
with the program’s administration. The Maine Drug Return Implementation Group was
also formed. This group was tasked with addressing postal regulations, methods and
requirements for mailing, minimizing drug diversion and theft of mailed returns,
providing public education, and encouraging the development of turn-in programs. This
mandate encouraged the implementation group to seek outside funds. A grant proposal
was made to the U.S. EPA Aging Initiative to pilot the program (findings and activities
covered in this report).
In 2007, the Maine Legislature enacted Maine LD 411 “An Act to Establish a Pilot
Program for the Return of Unused Prescription Drugs by Mail.” This initiative provided

See http://www.mainelegislature.org/ros/LOM/LOM121st/15Pub651-700/Pub651-700126.htm#P9390_1232537

16
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an additional $150,000 to the pilot which allows the program to continue for an
additional two years beyond the initial EPA grant.

Partnering with Law Enforcement is a Key Component
Close partnership with the Maine Drug Enforcement Agency (MDEA) provided the
critical involvement of law enforcement. By law, only law enforcement entities are
permitted to receive and handle returned pharmaceutical drugs classified as Schedules
II, III, and IV, which includes narcotic analgesics, sedatives, and stimulants.17 Their
involvement is necessary to insure security, to prevent drug diversion, and because the
law requires it. Because of the likelihood that controlled substances would be an
important subset of the returned drugs, the MDEA agreed to oversee receipt of drugs
returned via this program.

Maine’s mail-back program also required partnership with the MDEA in order to facilitate
use of the already-established incineration disposal method, as well as to actually
transfer the returned drugs for incineration.

Selecting a Central Coordinating Agency
From this base, the University of Maine Center on Aging (CoA) took the leadership role
in seeking funding for a pilot study from the U.S. Environmental Protection Agency’s
Aging Initiative. The Center on Aging has a number of characteristics that were
advantageous for this role. First, as a department within the University, the Center is a
qualified non-profit organization and therefore able to receive federal funding. The CoA
has the institutional base to act as the fiscal and administrative agent for what was to
become a highly visible and complex project. This includes qualified personnel,
experience with community/academic/government partnerships, and accessible,
centrally-located headquarters that can house meetings and coordinate
communications.

17

DEA Schedule of Controlled Drugs, http://www.justice.gov/dea/pubs/csa.html
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In addition, the CoA is well-known statewide and trusted by communities and elder
networks. They have established communication vehicles (website, newsletter, ongoing functions) to facilitate the education and marketing so essential for an innovative
project. The social network qualifications of the CoA proved to be beneficial during all
phases of the project.

Developing Organization Capacity
The following sections of this report provide some basic guidelines in developing
organizational capacity to address the problem of unused pharmaceuticals. If you are
just starting a program it is important to refine your organization’s intentions and clarify
how you wish to proceed. In other words, agreeing on a mission, goals, and objectives.
This is a necessary step not only in focusing your organization’s resources, but also a
requirement in order to seek external funding.

Each organization will be different. For that reason, we begin each of the following
three sections with basic instructions that can be applied broadly. We then use our
program as a specific example.

Developing a Program Mission
This first step focuses on your organization’s values with respect to the problem or set
of problems confronting your community. The mission statement should express what
you want your organization to be in relationship to that problem?
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Sample Mission:
As an academic‐community partnership concerned with the environmental risks posed by
the accumulation of unused household pharmaceuticals, we work together enthusiastically
to support and implement a successful mail‐back program.

You might begin by constructing the following: “We are [insert a phrase that describes
who you are as a group] who agree on the importance of [insert value/values] in
addressing [insert problem you want to solve], we will [insert what you have agreed to
do about it]. After you decide on these components, you can edit the statement to make
it flow better, for example: As an academic-community partnership concerned with the
environmental risks posed by the accumulation of unused household pharmaceuticals,
we work together enthusiastically to support and implement a successful mail-back
program.

Goals, Objectives and Outcomes
Deciding on goals, objectives, and outcomes will help your organization do more
effective planning and implementation. Articulation of these program components is
usually required by funding agencies. Check carefully with the agency funding
announcements, however, because agencies may differ in exactly how they define
these terms.

Goals are the general targets your program will aim for, usually phrased as some sort of
societal improvement. Setting goals is similar to setting a navigation course by pointing
your sights toward a star or a distant land mass. Goal statements can then be clarified
by defining and discussing concepts and terms used in the goal statements.

In contrast, objectives are specific, observable accomplishments that demonstrate
progress toward the program goals, or even define ultimate goal achievement.
Objectives can be mid-range or long-range. They can function as benchmarks or
Safe Medicine Disposal for ME: A Handbook and Summary Report y April 2010
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milestones, signals along the way that let you know your efforts are successful as you
move toward a goal. Or, long term objectives can be used to operationalize success in
arriving at the program goal.

Objectives should be indicators that can be agreed upon, even by an observer or
evaluator outside your organization. Objectives are useful for planning; they constitute
the day-to-day things the organization must actually mobilize itself to do. They should
be phrased in such a way that an administrator can use them in order to make decisions
about how to direct resources and personnel.

Maine’s Goals and Objectives
The goals for a prescription drug
Maine’s Goals
1. To devise, implement and evaluate a mail‐
back model
2. To test effectiveness of an educational
campaign about risks of improper storage
and disposal
3. Develop a framework for a national model
and ensure replicability

return program in Maine, were
two-fold: 1) to devise, implement
and evaluate a mail-back plan to
remove unused and unwanted
medications, both prescription and
over-the-counter, from residences
and dispose of them in compliance

with applicable state and federal laws and sound environmental practices, and 2) to test
the effectiveness of an educational campaign about the hazards to life, health, and the
environment posed by improper storage and disposal of unwanted medications. A costeffective model for the disposal of unwanted medication would be created and
implemented, and an educational campaign would be instituted in each of Maine’s 16
counties. Further, the project would address potential barriers to participation due to
age, infirmity, rural locale, and other challenges.
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Maine developed a list of 15 milestones and completion dates, which functioned in
effect as intermediate program objectives. These included first a model development
phase: (1) develop consolidation, transportation, and incineration protocols; (2) contract
with incineration facilities and transportation vendors; (3) commence meetings of
technical advisor task force; (4) secure network of 75 mailer distribution points
(pharmacies); (5) engage community advisory board and commence meetings; (6)
design and produce mailers, mailer survey, training materials for distribution site
educators, and instructions for pharmacies and the public; (7) create web site and
establish a toll-free helpline and helpline training
materials; (8) engage and train distribution site

Nuts & Bolts

educators; (9) develop public education campaign

Mission

content and dissemination plan.

Develop a program mission that
expresses in simple terms what
you want your organization to be.

The implementation included a Phase I to pilot the

Goals

program components, specifically: (1) launch Phase

Decide on program goals that
express what you want your
program to aim for in its work
overall.

I education campaign; (2) distribute informational
materials and provide training for pharmacists, staff,
and individuals acquiring mailers; (3) collect,
inventory, and destroy returned products from

Objectives
Define medium‐term and longer‐
term objectives, that is, clear
benchmarks that need to be
accomplished along the way in
order to demonstrate you are
achieving your goals.

Phase I locations in compliance with applicable
state and federal laws and sound environmental
practices statewide; and (4) evaluate Phase I and
refine for Phase II. Phase I program components
were implemented and designed to specifically

Outcomes
Describe the measureable
outcomes that will result if you
have met your goals.

target older adults and caregivers.

Objective milestones for Phase II included: (1)
distribute informational materials and provide

training for pharmacists, staff, and individuals acquiring mailers for Phase II; (2) collect,
inventory and destroy returned products; (3) generate, analyze and report on survey
and inventory data in a manner that allows physicians, pharmacists, insurance
companies, patients, and others to modify behaviors to minimize unused medications;
Safe Medicine Disposal for ME: A Handbook and Summary Report y April 2010

21

Maine’s Long Term Program Objectives
1. Conduct a statewide educational campaign on proper use and disposal
2. Calculate weight, type, and hazardous characteristics of returned medication
3. Calculate the cost of the mail‐back program model
(4) evaluate need for Phase III (and institute as necessary); (5) conduct final evaluation;
and (6) publish best practices handbook. It is important to note that Phase II expanded
the program exposure to population groups beyond older adults.

Maine’s long term program objectives included: 1) calculating the weight, type and
hazardous characteristics of returned medications by actual pill count and drug
classification; 2) calculating the cost of the mail-back program as a model for future use
nationally, by other organizations and states; and 3) offering a statewide education
campaign targeted toward the proper use and disposal of prescription drugs with an
initial focus on citizens 65 and older.

Projected outcomes included: 1) understanding the practicality and costs associated
with a mail back medication return program; 2) information on the best methods to
educate older adults concerning the hazards of unused medications and improper
disposal; 3) reduction in the amount of medications available for improper disposal,
diversion or poisoning; and 4) heightened awareness by the public-at-large and older
adults in particular that could lead to a reduction in accidental deaths, human and
animal poisonings, and suicides caused by unused medications.
Maine’s Expected Outcomes
1. An understanding of the model’s practicality and costs
2. Information on best methods to educate older adults about hazards of unused
and improperly disposed medications
3. A reduction in the medications in Maine available for improper disposal,
diversion or poisoning
4. Heightened public awareness, especially in older adults, of the risks caused by
accumulated or improperly disposed medications
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THE BASICS OF THE PROGRAM
Why Maine Mailback Participants Use the Program
Findings from program participant surveys from the Maine SMDME program itemized
multiple reasons for drug accumulation in their homes, including:
•

Medicine belonged to a deceased family member (19.6%)

•

A physician told the patient to stop taking the medication or gave the patient a
new prescription (27.3%)

•

The person had a negative reaction or allergy to the medicine (11.9%)

•

The person felt better or no longer needed the medicine (18%)

Participants also noted multiple reasons for removing the drugs from their homes,
including concerns for the environment, drug compliance, drug safety, as well as for
preventing drug diversion. Some noted they did not want anyone else to use the
medicine. Some were concerned about the potential poisoning dangers to children, or
the risks of drug abuse diversion. Often the medicine was expired or outdated and no
longer useful. In some cases this adds to their potential for misuse or harm.
Figure 1. Motivation for Using the Mailback Program

Motivation for Using the Mailback Program
N = 1828

16%

Best for the
environment

4% 3%
77%

Safest for me and
my family
Free to use
Most convenient

Nearly half (46%) of those surveyed reported that, in the absence of a take back
program, they would have flushed drugs down the toilet. Another one third (37%) would
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have dumped left over prescriptions into their trash. These disposal solutions can pose
environmental risks. Overwhelmingly, 77% of program survey respondents cited
participation because, “it’s best for the environment.”

Overwhelmingly, 77% of program survey respondents cited
participation because, “it’s best for the environment.”

Refining the Concept: The Mail-Back Model
There are five primary models for drug take-back programs. The first, a pharmacybased take back program, which is considered to be a controversial approach
nationally. Because returned medications often include Schedules II, III, and IV drugs,
which have a higher abuse potential, the DEA regulations require that they be received
and transported by law enforcement personnel.

In-person event-driven take back programs, the second model, are coordinated locally
(community-by-community) and would take the commitment of multiple police
departments and multiple law enforcement agencies to enact a statewide program.
Such events are offered sporadically and rely on local law enforcement to shoulder the
time commitment and costs associated with take back programming.

The third and fourth models, police department drop-off and pick-up, are emerging
models that have been developed through local community policing efforts. Both models
are not yet widely available but continue to grow in popularity in local communities.

The fifth model, a statewide mail-back prescription return program, was most
appropriate for Maine. It allows drugs to be returned directly to one agency, which
reduces coordination costs. In Maine, the Maine Drug Enforcement Agency (MDEA)
has statewide jurisdiction and had been involved in concept development. It was
therefore the most appropriate for piloting in Maine. The statewide mail-back model
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offers a centralized coordination component, adds an element of confidentiality and
anonymity not found with in-person take back programs, and is the least burdensome of
all models in terms of consumer participation (see Appendix 4E for a comprehensive
review of various models).

The statewide mail-back model offers centralized coordination…, adds
…confidentiality…, and is the least burdensome of all models in terms of consumer
participation.

Figure 2. Center on Aging staff member orients a participating pharmacist to the program

Tasks Leading Up to the Actual Mailback
Before a mailback can begin, there are a number of preliminary tasks that must be
accomplished. In Maine, this included the following (see Appendix 3 for complete
timeline):
•

Create consolidation, transportation, and incineration protocols

•

Contract with incineration facilities and transportation contractors

•

Commence meetings of technical advisory task force

•

Secure network of distribution points (pharmacies, community sites, etc.) to
which mailers are distributed in both phases
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•

Engage community advisory board members

•

Commence meetings of community advisory board

•

Design and create mailers and accompanying survey, training materials for
Distribution Site Educators and instructions for
pharmacies and public
•

Create web site, establish 800 number call center
and create related training materials and protocols

•

Engage and train Distribution Site Educators

•

Develop education campaign content and
communication dissemination plan

Figure 3. Each pharmacy
receives a program sign to
market the availability of
envelopes

•

Launch Phase I education campaign

•

Distribute informational materials for pharmacists,
staff, and individuals acquiring mailers for Phase I;
provide training

The Bottom Line: Costs and Funding
Below is the actual phase I and II budget for the Maine program. As noted, the perenvelope cost in the initial years of the program is significant given the staff time and
effort needed to create a novel program. Additionally, the value of donated time from
pharmacists and pharmacy tech staff totaled approximately $800 for each inventory
event toward the end of the project period. The time and effort contributed by
Community Educator volunteers was calculated to be $20.25/hour as estimated by the
Independent Sector.18

18

www.independentsector.org
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Phase I and II Actual Program Costs
(9,400 envelopes, 42% return rate)

Budget Line
Envelopes (including freight); supplies and materials
Assembly and printing (assumes color printing and survey printing and assembly)
Postage including PO Box permit
Disposal for both controlled and non-controlled drugs (2,123 pounds non-controlled and 250
lbs controlled)
DEA staff costs, data analysis consultants, research consultants
Website and Phone costs (User support)
Travel for cataloging/research activities/program administration
Staff time-program administration
Subtotal
Indirect Costs: Facilities, grant and contract administration, etc.
Total cost:
Per unit cost:

Actual Cost
$6,214.38
$9,358.62
$11,310.22
$7,111.00
$21,402.13
$4,237.53
$4,000.00
$50,002.12
$113,636.00
$36,364.00
$150,000.00
$15.96

In-kind provided to the project in Phases I and II
Per unit cost factoring both actual costs and in-kind provided

$26,607.13
$18.79

In-kind detail: 9,000 mailers donated by Polyair Manufacturing: $2,394.63; Time and
effort donated by Principal Investigator: $11,130; Pharmacist and pharmacy staff
donated time: $6,400; Community Educator volunteers (330 hours x $20.25 per hour
value): $6,682.50

Now that piloting has been completed for the program, the administrative costs for the
program have been reduced considerably. Below is the currently two-year operational
budget for the mailback program which includes enough funding to distribute and
process 20,000 mailback envelopes from across the state.
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Phase III Two-Year Budget
Base of 20,000 envelopes, 30% return rate assumption
Envelopes (including freight)
Assembly and printing (assumes color printing and survey printing and assembly)
Postage ($2.50 average per returned envelope)
Postage Fees (permit and PO Box for one year)
Disposal
DEA staff costs
Cataloging, data entry, data cleaning, reporting (pharmacist time, data entry staffing)
General supplies
Website and phone costs (User support)
Travel for cataloging/research activities/program administration
Staff time-program administration (40%FTE)
Volunteers (training, travel, support costs)
Subtotal
Indirect costs (13.4%) charged on all direct costs except volunteer/participant support

$6,200
$12,000
$15,150
$1,850
$16,000
$10,200
$12,000
$3,800
$2,805
$3,000
$47,506
$2,000
$132,511
$17,489

Total cost:
Per unit cost:

$150,000
$7.50

* budget assumes 30% return rate after Phases I & II

Implementation Structure
The Safe Medicine Disposal for ME mail-back model was conceived in two phases and
has since moved into a third phase:
Phase I Overview: In this pilot program, 1,800 postage-paid, padded mailers were
made available to consumers at 11 pre-selected pharmacies in four Maine counties
(see Figure 4). Counties were selected for their geographic disparity, access to rural
and urban communities, and demographic characteristics of residents (age,
socioeconomics, education, culture, lifestyle, etc.). This initial phase allowed staff to
monitor the program, pilot protocols, and revise as needed before Phase II
implementation went statewide. Phase I did not include marketing strategies or a
public education component, and there was limited press coverage of the program.
Only persons aged 65 or older and their caregivers were encouraged to participate.
Phase II Overview: Safe Medicine Disposal for ME went statewide in Phase II with
7,600 mailers available in all 16 Maine counties (see Figure 4). Initial envelope
distributions to sites during this phase were based on county population size.
Pharmacies continued to be the primary point of distribution for program envelopes,
although site selection expanded to include health agencies, doctors’ offices, social
Safe Medicine Disposal for ME: A Handbook and Summary Report y April 2010

28

service programs, and Area Agencies on Aging. This phase included a public
education component with extensive, targeted marketing urging individuals into
distribution centers for the purpose of picking up and using return mailers. All age
groups and caregivers were eligible to participate in the program.
Phase III Overview: During Phase III the program was expanded to additional sites
within the state’s 16 counties (see Figure 5). The program remains open to
participants of all ages.
Safe Medicine Disposal for ME
The Process At a Glance
•

Distribution sites are solicited and trained (Appendix Group 5 includes Distribution Site
materials)

•

Volunteer staff are trained (Appendix Groups 6 includes Helpline and Volunteer
materials)

•

Brochures and other educational materials are created, and volunteer staff begin
presentations in communities (Appendix Group 8 includes Consumer Education Items)

•

Volunteer staff distribute postage-paid, padded return envelopes to pharmacies and
other health and social service agencies across the state at no cost. (Appendix Group 7
includes information on Mailback Materials).

•

Pharmacy and agency staff give an envelope which includes an instruction packet
(Appendix 7A) and a consumer survey (Appendix 7C) to any interested participant.
o

Participants are asked to use a black permanent marker to write over the name of
the person for whom the prescription was written. They are asked not to write
over the name of the medicine or the dose.

o

Liquids or creams are to be wrapped in a paper towel and placed in a Ziploc bag.

o

Sealed medicine bottles along with any Ziploc bags of liquid are to be put into the
padded self-addressed return envelope and sealed.

•

Participants return the completed survey and drugs to the Maine Drug Enforcement
Agency (MDEA) using the postage-paid return envelope provided.

•

Participants are asked to write down the envelope code written on the corner of the
medicine envelope and call the program help line to leave a message with the envelope
code and the date it was mailed.

•

Envelopes are received and held by the U.S. postal service.

•

Drug enforcement agency officials pick up collected envelopes periodically and take to a
secure central location where they are logged and catalogued. Questionnaires are
returned to the Center on Aging for analysis at the time of cataloging.

•

Medicine is destroyed via incineration.
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Figure 4. Map of Phase I and Phase II distribution locations showing township population density
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Figure 5. Map of Phase III distribution locations showing township population density
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The Mailer
Center on Aging staff tested a variety of padded mailers. There are many to choose
from depending on project budget constraints, and selecting the size of a chosen mailer
will have cost implications. Minimally, mailers need to have a tamper-evident seal and
should be nondescript--not easily identifiable as containing drugs. Mailers chosen for
Safe Medicine Disposal for ME are 7.25 x 12 inches and can hold four different bottles
of prescriptions and six to eight ounces of drugs, although it has held up to a pound of
drugs. The specific mailer chosen was the XPak mailer manufactured by Polyair. 19
Figure 6. Stack of mailback envelopes

In Maine, each mailer is
accompanied by a questionnaire
along with an instruction booklet on
how to properly prepare and mail the
envelope (see Appendix Group 7).
The questionnaire is designed to
assess the nature of the returned
product(s) as well as reasons for
their return. Information collected
includes basic demographic data,
source of contents, patient
identification of contents and reasons for surplus.
During Phases I & II, 9,400 envelopes were distributed and 3,926 envelopes were
returned generating 2,373 pounds of unused and unwanted medicines. As reported by
the Community Medical Foundation for Patient Safety, almost 17% of medications
returned through the Maine Program were found to be controlled drugs (see “What We
Have Discovered” section of this report). Older medications have not been uncommon;
some of the prescriptions returned were noted to be twenty or more years old. It is also

19

For more information visit www.xpak.com
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estimated that several of the envelopes returned to date have contained enough unused
narcotics to net thousands of dollars if sold on the street.

The Mail System & The USPS
In Maine, an “operational test agreement” was formed between the U.S. Postal Service
and the Maine Drug Enforcement Agency – the first of its kind. Operational test
agreements are traditionally crafted so the postal service can test out novel options.
Figure 7. Phase I envelope shipments to
distribution sites were prepared in-house at the
Center on Aging

These agreements are time limited
contracts, and each state will need to
pursue an agreement within their own
state. Because there had been no
previous template for this sort of
agreement, the process in Maine took
more than a year to finalize. Important
decisions to be made include the type of
mailer to be used, how to educate the
public about the program, and how to
ensure the safe delivery of envelopes to

the receiving drug enforcement agency. A copy of the Memo of Understanding between
the U.S. Postal Service and the Maine Drug Enforcement Agency is provided in
Appendix 4D.
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Figure 8. CoA staff member prepares Phase I envelope shipment to pharmacies

Figure 9. Phase I boxes ready for shipment to program sites

When The Mailers Come In, Then What?
Using a double verification process, MDEA law enforcement personnel count and
collect returned mailers from the Post Office on a regularly scheduled basis and take
them directly to a secure consolidation facility. The audit process involves a repeat
count of the number of packages received and verification of accounting logs conducted
by the UMaine Center on Aging. Throughout the process the MDEA maintains
continuous, unbroken custody of the returned medicine.

Cataloging of returned drugs was done under law enforcement supervision by volunteer
project pharmacists and pharmacy students. As participation has increased over time,
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the program has moved from cataloging 100% of returns to a 25% random sample to a
20% random sampling procedure. Using a sampling method was found to be both cost
effective and yielded a data sample that was statistically representative of the full
inventory data set. For the envelopes that do not receive a full inventory, all noncontrolled drugs are sorted for disposal, and all controlled drugs are fully inventoried.

During the cataloging, drugs were sorted according to whether they were controlled
drugs or not and further into controlled hazardous or controlled non-hazardous
categories.20 This sorting method facilitates appropriate disposal and therefore helps
control disposal costs.

Figure 11. Boxes of inventoried medicine
Figure 10. Volunteer pharmacists and pharmacy
staff inventory returned medicine

Figure 12. Drugs are occasionally returned mixed
together and without their original container.

20

Figure 13. Returned consumer surveys
collected at a drug inventory event.

Very few drugs have been found to be both controlled and hazardous.
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Collection, Inventory and Disposal Requirements
In compliance with the Maine Drug Enforcement Agency and the Department of
Environmental Protection, drug collection, inventory and disposal included the
following elements:
1) Double verification of returns
2) One secure collection and consolidation facility
3) Repeat count of the number of packages that have been received
4) Proper disposal of all drugs collected
5) Continuous, unbroken custody by law enforcement from receipt to disposal

Disposal Mechanics
Various methods of disposal, good and bad, for collected prescription drugs have been
traditionally used by consumers and facilities including: flushing down the toilet,
throwing medication out in the trash, burying in a landfill, burning, or mixing substances
with kitty litter and used coffee grounds to make results undesirable. In Maine, drug
disposal options were to be considered if they satisfied the requirements and standards
of the Department of Environmental Protection and the Maine Drug Enforcement
Agency. Maine DEP has classified drug returns as hazardous waste, while other states
may classify drugs differently. All non-controlled drugs collected by the mailback were
incinerated as hazardous waste. All controlled drugs were disposed of through
incineration with a witness from the Maine Drug Enforcement Agency to certify that the
drugs were in fact destroyed.
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Volunteer Workforce: Elder Involvement is a Critical Component
It cannot be stressed enough how important volunteers, in particular older adult
volunteers, are to the program. The first two external groups to be developed, the
Community Advisory Board and the Distribution Site Educators, are outlined below.
Members were recruited by print, broadcast, and word-of-mouth.

In Phase I, the 15-member Community Advisory
Board was comprised of volunteers age 65 and
older recruited from the Retired Senior Volunteer
Program (RSVP), Maine Area Agencies on
Aging, and other older adult organizations and
associations from urban, rural, and suburban
areas in each county represented in the pilot
Figure 14. Community Educator
volunteer orients community
pharmacist to the mailback program

project. Board members reflected the
population’s diversity by gender, socioeconomic
status, and education. In the early stages,

Community Advisory Board members attended monthly meetings and acted as a
sounding board for the project, in part to review brochures, instruction booklets, and
marketing strategies for applicability to an elder community. The board has also
provided valuable insight into the rural Maine communities represented by individual
members.

Volunteer Distribution Site Educators included community members from around the
state and Community Advisory Board members. In Phase I, their purpose was to
deliver mailers and materials and to educate distribution site pharmacists and staff
about the program process. This role was discontinued for a variety of reasons, one
being that pharmacies were often too busy to meet with Educators and orientation
materials as designed were fairly self-explanatory. Beginning in Phase II, Educators
organized and attended meetings at local Chambers of Commerce, Kiwanis clubs,
senior centers, and nursing homes to educate members of their own communities about
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the mail-back program. Presentations included a PowerPoint slideshow, a presentation
quiz, and handouts (Appendix Group 8).

Evaluation data for community education sessions were gathered via a post-session
survey tool. One hundred and fifty-one surveys (151) from education session
participants were gathered and analyzed. Participants in community outreach and
education presentations range in age from 20 to over 80 years old. The majority of
participants were within the 60-80+ age range. Eighty-seven percent of participants are
female and 13% are male. Ninety-four percent (94%) of participants had never
participated in a community drug disposal event prior to attending the education
session. This indicates that the presentation is often touching upon new topics and
disposal issues to which participants had not yet been exposed. Ninety-seven percent
(97%) rated the overall drug disposal presentation as “good” or “excellent.” The average
exam score on post-presentation evaluations was 95/100 indicating that the training has
a high level of impact on knowledge. A sampling of comments from education session
participants:
•

Very helpful/informative

•

This information is very important!

•

Hank (CAB volunteer) has a wonderful way of presenting and relating to people.
His talk was very well received by folks at the Knox county TRIAD meeting

•

Very necessary information! Well done!

•

Lynn (CAB volunteer) was great with the women attending!

•

Well done! / Good job!

•

Important information-much needed in our community!

•

It is my understanding when people take meds, then urinate, the meds end up in
the sanitation systems and cause gender confusion.

•

Great! Entertaining and informative

An additional avenue for volunteering with the Maine program was the use of volunteer
pharmacists from distribution sites who were recruited to catalogue returned drugs.
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Pharmacy tech staff and students volunteered their time under supervision of the
pharmacists to assist in data collection. This assistance was provided by Miller Drug, a
local community pharmacy, volunteer licensed pharmacists, along with faculty and staff
from Husson University School of Pharmacy, and the University of New England
College of Pharmacy.

Communication Systems
The mailback program utilized several project-specific communication vehicles, two-way
communication “channels,” to stay in touch with a primary network of advisors and to
interact with the public: meetings, a consumer website, and a helpline. In addition, the
Center’s newsletter Silverwire often contained project updates. Two-way
communication allowed the project to be responsive to unanticipated problems.

Regular meetings of both the Technical Advisory Board and the Community Advisory
Board offered an opportunity for the project staff to share successes and problem-solve,
and to receive and send feedback to/from the public and other concerned stakeholders.

The project website (www.safemeddisposal.com) provided a “one-stop-shopping”
solution for people who wanted to know about the project or check policy changes. The
website was heavily used by both local and out-of-state persons interested in the
project. In addition, website visitors were able to send an email inquiry to project staff.
During the last most recent reporting period, for example, project staff received
approximately one email a day during the work week. E-mail was used most by
caregivers and professionals. Caregiver requests were usually for an envelope to be
mailed to them because a nearby site location was not available via the program.
Professional inquiries tended to come from pharmacies and other sites interested in
participating in the program. Additional requests that came in by e-mail were from other
states looking for information on the program for replication purposes. A sampling of
states requesting information about the program model include: Oregon, Washington,
D.C.; New York; California; Florida; New Hampshire; and Washington. As an example
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of the national impact of the pilot, please see the U.S. Postal Service press release in
appendix group 4.

The helpline, which was staffed by student interns, proved to be a very critical
component of the program communication system. This phone number was liberally
circulated to pharmacies and community sites, and was found on virtually all program
informational material. During a recent three-month reporting period, the project
received 727 calls, an average of more than 10 a day during the workweek. Two
thousand seven hundred and seventy-seven (2,777) calls were received over the 2.5
year reporting period. Many of these have been from individuals calling the program to
alert staff that they were mailing an envelope. Additional sources of inquiries included
pharmacies, healthcare, and community sites that are interested in becoming
established distribution sites. Thus the helpline functions in recruitment as well as
information exchange.
Communication “Channels”
1. Advisory board meetings
2. Project website
3. Project helpline
4. Agency newsletter
5. Media releases
6. Public presentations
7. Evaluation forms at community education sessions
8. Survey instruments inside mailers

Feedback Loops: Tracking and Evaluation
Feedback loops existed as a function of the evaluation forms distributed at each
community education event. These events were usually staffed by volunteer community
educators trained for the project. In addition, each mailer contained a short survey,
which was designed to learn about the demographic profile of the participant, the
reasons for participating, the sources of the drugs, and the reason they had
accumulated.
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But beyond these basic tracking mechanisms, a thoughtful program evaluation should
be a critical component of any publicly funded effort. Without well-designed evaluation
methods, programs do not have systematic ways to measure success, to improve
systems, or (minimally) to programmatically account for their expenditure of public
monies.

Program evaluations should track and account for whether the program meets is
benchmarks along the way as outlined in the workplan (formative evaluation). These
feedback mechanisms should be built into the project’s internal information systems. In
addition, program evaluations should assess whether the project met its overall goals,
as indicated by measurable outcomes (summative evaluation). Programs often find it
challenging to identify outcome measures that clearly reflect the efforts of the project in
achieving its goals.

If they are to be used for quality improvement, outcome measures should ideally be
selected to reflect processes over which the project has some control and which move it
toward its selected goals. In other words, depending on the outcomes, one should be
able to actively “tweak” the systems, if necessary, in order to get an improved result.
The link between program effort and its outcome should be clear (visible) and
measurable (ideally by an objective observer) in either qualitative or quantitative terms.
It is only when both the process and outcomes are documented that the program has
the potential to become “evidence-based,” evidence being the best source of informed
policy.

Public Relations and Marketing
A unique education campaign was implemented for Maine in two phases. In Phase I,
education provided by the program was done via the program website and program
brochures and tipsheets. The purpose of these materials was to enlighten the public on
the hazards to life and health posed by unused drugs. The explicit message and goal
was to reduce/eliminate unused medications in circulation and improper disposal
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because of the significant potential for human and environmental harm as well as to
advance public knowledge about protecting, sustaining and restoring the environment.
The Phase II campaign built upon the messages established in Phase I and
incorporated a new message encouraging the public to visit distribution sites statewide
to acquire and use mailers. Phase II education efforts were rolled out locally via multiple
media channels and local in-person presentations by volunteers in a more extensive
and purposeful fashion than in Phase I to measure the impact that such education
would have on the use of the program.

Because of the higher rate of pharmaceutical usage among older adults and the higher
risk of accidental misuse and/or overdose within this population, special emphasis was
placed on crafting cohort-specific messages during both phases and utilizing
communication channels targeting specific user groups.

Effective Use of the Media
Communication with the public via print, digital, and broadcast media constitutes an
essential part of program planning (see Appendix Group 9). The University of Maine’s
Public Affairs department was routinely used as a vehicle to develop and circulate press
releases. Staff generated program drafts of press releases and welcomed input from
those who specialize in this type of communication. Relationships between programs
and such specialists, including public information officers, journalists, news anchors,
and other writers can be very helpful in designing interesting and appropriate material
that targets particular readerships/audiences. They used material the program
generates and augmented it for their particular purpose, sometimes with an interview of
program staff or program volunteers.
Program staff encouraged volunteers and partner organizations to “get the word out” by
providing basic informational materials so that there was a uniform source for basic
facts and concepts while leaving room for each outlet to augment the material as
appropriate. For example, a media template was provided to local papers and
community contacts that could be used as a backdrop for a story about a local person,
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group, or educational event. An example of the template is included in Appendix Group
9.

Material generated for local community education, such as PowerPoint presentations,
was made accessible for interested and involved citizens to use. This accessibility is
important in increasing the speed at which a new idea (the drug mailback concept) can
reach a large number of people. In this way, media and publicity efforts dovetailed with
the heavy use of volunteers for outreach, training, and communication.

The Value of Research
Whether or not you plan to do any formal research as a part of your mailback program,
research findings will nevertheless flow from your efforts. The experience gained by
conceiving, planning, and implementing this program will include conclusions based on
information. It will probably also include evaluation findings about how you reached
your objectives, how well certain efforts worked, and ways your program is similar or
different than others like ours. We strongly recommend that, at a minimum, you take
advantage of your experience by carefully documenting your plans, progress, and
experience. Your documented findings will be of use in (1) educating others about your
program, (2) building political support for future programs, (3) writing proposals to
funding agencies to obtain funding, and (3) designing public policies in your region and
nationally. Simply collecting weight or estimated dollar value of the drug returns
collected provides very little precise data on which to formulate policy or useful insights
on drug accumulation.
Some levels of research are limited by resources, but should be attempted if possible.
In particular, cataloging the drugs returned requires secure settings and professional
input from pharmacists and healthcare volunteers, as well as some research skills to
analyze the results. Ideally, funding is allocated in your budget ahead of time for some
research. Sometimes, as is the case for the Maine program, volunteers can boost your
efforts. For example, local schools of pharmacy may be interested in using this as an
educational experience for students. The program also partnered with the Community
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Medical Foundation for Patient Safety in Texas, which is working to establish a national
database of drug returns to assist in research design and data analysis.

Take-back programs are in their infancy, but growing fast. Because of their potential
impact on environmental policy, healthcare policy, and public safety, it is very important
that good data are developed describing their scope and impact. Knowledge about the
amount of excess drugs collected in Maine has been informative in refining Maine
Medicaid policy, for example, leading to limits for some drugs on how much can be
prescribed (see Appendix 4F regarding the new 15-Day Rule). And the Maine state
legislature, along with other states, is considering new product stewardship laws that
would require pharmaceutical companies to cover the cost of drug disposal.

What We Have Discovered with Our Program Research
The short survey included with each mailback envelope yielded vast amounts of data on
the demographic characteristics of participants, the reasons drugs had accumulated in
their households, and reasons for participating in the program. Each envelope has a
code number pre-printed on the front which allows for linking survey data directly to
drug inventory data. Several databases are currently maintained by the program
including: envelope tracking and distribution databases, a survey database, a database
with community education session evaluations, drug inventory data, and helpline
communication logs. These data are valuable indicators for future programs and helpful
for designing program materials and community education.

As the program continued into Phase II, increasing demand by non-pharmacy
organizations lead to the expansion of distribution channels to a wider range of
distribution sites, including home health agencies, doctor’s offices, social service
programs, and Area Agencies on Aging. After examining returns patterns, a trend was
noted that revealed that returns are directly related to the population size within the
areas where sites are located. However, the rate of return for each site was not
calculated. As such, site locations and distribution patterns for the program were
modified to ensure that envelope stock is used in an efficient and appropriate manner.
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Maine’s program was targeted for elders initially, although program staff quickly
anticipated that it made sense to expand to adults of all ages given the drug abuse and
death trends within the state. However, it was discovered that starting with older, retired
citizens was a very effective strategy to launch this new concept. First of all, they are
likely to have more prescriptions and more likely to be willing and available to assist in
the program as volunteers. The average age of program users in Phase I was found to
be 70 years of age; once the program opened up to adults of all ages, the average age
of program participants (those who return drugs using the envelopes) was found to be

Safe Medicine Disposal for ME Phases I & II
Snapshot
•
•
•
•
•
•
•
•
•
•

$150,000 in funding provided by the U.S. EPA to pilot in Phases I & II
9,400 envelopes distributed
3,926 envelopes collected (42% return rate)
Over 380,000 pills cataloged via the drug inventory process
2,074 surveys collected and analyzed
2,777 telephone calls answered via the program helpline
2,123 pounds of non‐controlled drugs destroyed
250 pounds of controlled drugs destroyed
Average weight of a returned envelope: 7 ounces
Estimate Average wholesale price (AWP) of medicine collected: $572,772.35 (US
Dollars)*
Value of donated envelopes by Polyair, donated time by Principal Investigator,
pharmacist, student, and volunteer time donated to the program: $26,607.13**

Percentage of individuals using trash or toilet to dispose of drugs prior to the program =
83% x 2,373 lbs of drugs = 1,970 lbs of drugs prevented from entering the water supply
and landfills
*Estimate provided by Community Medical Foundation for Patient Safety based on sampling. MAC, or
Maximum Allowable Cost, was not calculated
** See “The Bottom Line” section of this report.

59 years, with 65% of participants being female. Households participating in the
mailback program were more likely to have adults rather than children living in the
household. However, nearly one quarter of the participating households had a teenager
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in the household or a child under the age of 10 years old. This information was tracked
to measure the potential for preventing accidental poisonings or drug diversion.
Figure 15. Household Makeup of Mailback Program Users
Household Makeup
N = 1,759

21-64 year olds

60

55.8

65 and up

50
40

46.5
11-20 year olds

% responses 30
20
10

15.1

10

Children up to 10 years
of age

0
Age groups of residents in the household

Participants indicated a number of reasons the drugs had accumulated in their
household. The most frequent reason given was that the medicines were now expired
or outdated.21 The second most common reason was that the doctor had told the patient
to stop taking the medicine. Other reasons were that the doctor had given them a new
prescription, that they had had a negative reaction or allergy to the medicine, or that the
patient felt better or no longer needed the medicine. A substantial number of
participants wanted to prevent anyone else from using the medicine. The openresponse option for this question also yielded a considerable portion of respondents
who were returning medicine for a deceased loved one. Based on these data, we began
tracking the portion of respondents returning medicine for a deceased family member or
friend. Most drugs returned via the program were obtained at a local pharmacy (84%) or
by mail (14%).

21

Older medications were not uncommon. Some were prescriptions noted to be as many as 20 or more years old.
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Figure 16. Reasons for Unused/Unwanted Medicine

Why do you want to get rid of these medicines?
N = 2,041

Expired
Doc told me to stop taking it
Doc gave me new medicine

50
Did not want anyone else to
use it
Other

47.4
40
30
%

Felt better

31.1
27.3

20

Didn't like the side effects

25.4
24.2

10

11.9
0

Had a reaction or allergy

7.2

18 12.2

0.7

Didn't want to take it
I don't know

Reason

Our survey findings show that keeping household medications organized and up-to-date
can be an important and constant chore, not only for patients, but also for their
caretakers. In fact, while 41% were returning medicine for themselves, thirty-five
percent (35%) were returning medicine for a relative, and nearly 20% were returning
medicine for a deceased friend or loved one22. The decision about what to dispose of
can be complex as indicated by the fact that 16% of our respondents did not know what
kind of medicine they were returning.

Many survey questions allowed the respondent to select more than one response option thus not all percentages
within the charts provided will add up to 100%

22
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Figure 17. Source of Medicine Returned

Whose medicine is returned?
N = 2,049

41

50

35.1

40
% of returns

My own
Relative
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Friend
Pet
Don't know

30
20
19.6 5.3 2.9

10

1.2

0
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the Medicine

Figure 18. Type of Medicine Return: Self Report
Type of Medicine Returned: Self Report
N = 1,597

40
35
30
25
% 20
15
10
5
0

Pain & anti-inflammatory

35.2

Other

35
32.1

Heart, blood, cholesterol
Sleep & anti-anxiety

21.2
16.2 16

Antibiotics

10.1
Don't know

Type of Medicine

Allergy medicine

Prior to this program, participants said that they usually flushed medications down the
toilet (46%) or placed them in the household trash (37%). A smaller number said they
had attended community drug collection events (5%).

Most participants (77%) indicated that concern for the environment was a significant
factor in their decision to use the mailback program and 16% cited safety for themselves
and their families.
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Figure 19. Disposal Methods Used Prior to Mailback Program

How did you normally dispose of your unused
and unwanted medicine before today?
Flush
5%

8% 4%
46%

Trash

37%
Collection event
Don't know
N = 1334

Other

A very important source of data about our program came from the cataloguing of the
drugs themselves. We received mostly pills, but also gels, creams, inhalers, and other
items. Nearly all (86%) of the returns were prescription drugs, and 12% over-thecounter. The vast majority of returns represented prescription drugs consumed by
humans as compared to the negligible amount of veterinarian medicines returned using
the program.
Figure 20. Controlled Drug Status of Returned Medicine
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About 17% of the drugs were schedules II, III, and IV –“controlled drugs.” These
include narcotic pain relievers, tranquilizers and sedatives, as well as stimulants. These
are the drugs that are sometimes diverted for “street” use or sale. Controlled
substances were equally likely to be returned by males (14%) and females (15%) (no
statistically significant difference). The rate of controlled substances returned increased
slightly with age, but the differences were not significant.

Figure 21. Over-the-County Returns vs. Prescription Medicines

Figure 22. Human vs. Veterinarian Medicines Returned
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Most returns were in pill form. Fourteen percent of returns represented liquids, gels,
ointments and patches. A negligible amount of medical supplies and devices were
returned including unused morphine pumps.
Figure 23. Form of Returned Medicines

Full, unused bottles were sometimes returned, including prescriptions from mail-order
pharmacies or VA pharmacy services, as well as anti-retroviral drugs for HIV/AIDS
treatment. It was not uncommon to find a mix of local and mail order pharmacies
represented sometimes where a patient was receiving the same drug from both
sources.

Drug data were classified into therapeutic categories by the Community Medical
Foundation for Patient Safety using the Drug Abuse Warning Network system (DAWN).
The following chart produced by the Community Medical Foundation for Patient Safety
demonstrates that the CNS agents, cardiovascular agents, and psychotherapeutic
agents were the top three categories of drugs returned through the program.
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Figure 24. Therapeutic Category Breakouts of Returned Drugs by Number of
Prescriptions/Medications Collected
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Difference Noted on Therapeutic Classes of Drugs Returned
A subset of data was examined to determine gender and age‐related
differences among users and the drugs they returned:
•

Males returned more anti‐infectives, cardiovascular agents and metabolic
agents.

•

Females returned more gastrointestinal agents, hormones, psychotherapeutic
agents and respiratory agents [Chi sq. = 39.52, df = 14, p < .000].

•

Participants 50 years of age and younger were less likely than their older
counterparts to return most classes of drugs, with the exception of
psychotherapeutic agents.

•

Top drug classes by age are as follows: Participants 75 or older: cardiovascular
agents (19%); 65 to 74: hormones (7%); 50‐64: metabolic agents (17%).

Figure 25. Therapeutic Subclass Breakouts of Returned Drugs by Number of
Prescriptions/Medications Collected

FREQUENCY COUNT BY THERAPEUTIC CATEGORY, THERAPEUTIC SUBCLASS 1,
THERAPEUTIC SUBCLASS 2
(Total=11382 Items)

THERAPEUTIC CATEGORY-Therapeutic Subclass 1
No therapeutic category available
ALTERNATIVE MEDICINES
Drug names not available
Herbal products
Nutraceutical products
Probiotics
ANTI-INFECTIVES
Drug names not available
Amebicides
Aminoglycosides
Anthelmintics
Antifungals

Count of
Therapeutic
Category
328
59
6
26
19
8
776
4
42
10
1
62

%
2.88
0.52

6.82
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Antifungals, Azole antifungals
Antimalarial agents
Antituberculosis agents
Antiviral agents
Cephalosporins
Cephalosporins, First generation
cephalosporins
Dermatological agents
Leprostatics
Lincomycin derivatives
Macrolide derivatives
Miscellaneous antibiotics
Penicillins
Quinolones
Sulfonamides
Tetracyclines
Urinary anti-infectives
ANTINEOPLASTICS
Antimetabolites
Hormones/antineoplastics
Tyrosine kinase inhibitors
BIOLOGICALS
In vivo diagnostic biologicals
CARDIOVASCULAR AGENTS
Drug names not available
Antiadrenergic agents, centrally
acting
Beta-adrenergic blocking agents
Calcium channel blocking agents
Calcium channel blocking agents,
Cardiovascular agents NTA
Cardiovascular agents NTA,
Angiotensin converting enzyme
inhibitors
Cardiovascular agents NTA,
Angiotensin II inhibitors
Cardiovascular agents NTA, Inotropic
agents
Diuretics
CNS AGENTS
Drug names not available
Analgesics
Analgesics, Miscellaneous

12
8
1
33
97
16
1
1
27
72
5
151
97
57
54
25
42
3
37
2
1
1
1687
1

0.37

0.01
14.82

32
287
194
21
671
121
8
2
350
2613

22.96

1991
4
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analgesics/combinations
Analgesics, Nonsteroidal antiinflammatory agents
Anorexiants
Anticonvulsants
Anticonvulsants, Fatty acid derivative
anticonvulsants
Antiemetic/antivertigo agents
Antiparkinson agents
Miscellaneous CNS agents
Muscle relaxants
Muscle relaxants, Skeletal muscle
relaxants
COAGULATION MODIFIERS
Anticoagulants
Antiplatelet agents
Miscellaneous coagulation modifiers
DRUG UNKNOWN
GASTROINTESTINAL AGENTS
Drug names not available
5-aminosalicylates
Antacids
Antidiarrheals
Digestive enzymes
Functional bowel disorder agents
Functional bowel disorder agents,
Serotoninergic neuroenteric
modulators
Gallstone solubilizing agents
GI stimulants
H2 antagonists
Laxatives
Laxatives
Miscellaneous GI agents
Proton pump inhibitors
HORMONES
Drug names not available
Adrenal cortical steroids
Bisphosphonates
Miscellaneous hormones
Sex hormones
Sex hormones, Contraceptives
Thyroid drugs

1
2
231
26
123
50
76
101
6
168
122
39
7
172
733
6
15
18
65
14
50
2
5
41
78
172
4
28
235
441
1
170
29
22
110
2
82

1.48

1.51
6.44

3.87
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Thyroid drugs
IMMUNOLOGIC AGENTS
Bacterial vaccines
Immunosuppressive agents
Viral vaccines
METABOLIC AGENTS
Drug names not available
Antidiabetic agents
Antigout agents
Antihyperlipidemic agents
Antihyperlipidemic agents, HMG-CoA
reductase inhibitors
Glucose elevating Agents
MISCELLANEOUS AGENTS
Drug names not available
Antidotes
Antirheumatics
Chelating agents
Genitourinary tract agents
Miscellaneous uncategorized agents
Smoking cessation agents
Viscosupplementation agents
NON-ALCOHOL ILLICITS
Stimulants
NUTRITIONAL PRODUCTS
Misc
Iron products
Minerals and electrolytes
Oral nutritional supplements
Vitamin and mineral combinations
Vitamins
OTHER
PSYCHOTHERAPEUTIC AGENTS
Antidepressants
Antipsychotics
Antipsychotics, Miscellaneous
antipsychotic agents
Anxiolytics, sedatives, and hypnotics
CNS stimulants
RESPIRATORY AGENTS
Drug names not available
Antihistamines

25
12
1
9
2
765
6
284
63
382
21
9
169
13
5
3
3
100
29
15
1
5
5
377
19
9
145
1
86
117
12
1672
610
300
27
565
170
789
1
180

0.11

6.72

1.48

0.04
3.31

0.11
14.69

6.93
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Bronchodilators
Decongestants
Expectorants
Respiratory agents NTA
Upper respiratory
Upper respiratory combinations
TOPICAL AGENTS
Drug names not available
Anorectal preparations
Antiseptic and germicides
Dermatological agents
Dermatological agents, Topical
antibiotics
Mouth and throat products
Nasal preparations
Ophthalmic preparations
Ophthalmic preparations, Ophthalmic
glaucoma agents
Otic preparations
Vaginal preparations
Grand Total

275
36
13
123
1
160
561
7
6
8
209

4.93

3
10
80
198
12
11
17
11382

100.00

Through research both the environmental risk and the environmental hazards of the
drugs returned through the program were assessed. All items for which data were
available were found to pose at least some environmental risk. Environmental risk refers
to risk of acute toxicity to the aquatic environment. Environmental risk is based on the
ratio of predicted environmental concentration of the substance (PEC) and the highest
concentration of the substance that does not have a harmful effect in the environment
(PNEC)23. Environmental Risk is specified as follow:

Risk

Condition

Value

Insignificant if PEC/PNEC

<0.1

Low

if PEC/PNEC

0.1–1

Moderate

if PEC/PNEC

1–10

23 More detailed information is available at www.fass.se and
www.janusinfo.org/imcms/servlet/GetDoc?meta_id=7236
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High

if PEC/PNEC >10
Figure 26. Potential Environmental Risk of Returned Medicine

POTENTIAL ENVIRONMENTAL RISK
(DF=33, Var Name=RISK)
(Total=11382 Items)

The potential environmental hazard assessment of the active pharmaceutical substance
is based on the three characteristics of persistence (P), bioaccumulation (B), and
toxicity (T). Each characteristic is assigned a numeric value (0–3). The total of the
values comprises the PBT Index of the substance with 0 being the lowest PBT rating
and 9 being the highest score representing the highest degree of environmental hazard.
Environmental hazard assessment is based on the JANUS Classification System,
accessed at http://www.janusinfo.se/imcms/servlet/GetDoc?meta_id=6913.

JANUS Classification System (Janusinfo) is a public-domain website that provides drug
information to support healthcare professionals and environmental scientists to
understand better the wide range of pharmaceutical products and their potential impact
on the environment. The Drug Therapeutic Committees and the Department of Drug
Management and Informatics in Stockholm County Council, Sweden maintain this
website and periodically update the information.
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Figure 27. Potential Environmental Hazard Posed by Returned Medicine

POTENTIAL ENVIRONMENTAL HAZARD
(DF=34, Var Name=PBT; DF=35, P; DF=36,B; DF=37,T)
(Total=11382 Items)

Classification is made of both the medicines’ inherent ability to affect the environment
(environmental hazard) and the environmental risk posed by the pharmaceutical
substances when used to their current extent. The Environmental Department of
Stockholm’s County Council initiated the environmental hazard assessment based on
data submitted by pharmaceutical manufacturers in 2003. The classification system
includes environmental risk assessment, which was conducted by the Swedish
Association of the Pharmaceutical Industry in 2005.

While the Swedish and European pharmaceutical market overlaps with that of the U.S.,
some medicines (generic categories) available in the U.S. may not be listed in the
current JANUSINFO. Project Investigators along with the Community Medical
Foundation for Patient Safety researched and evaluated many classification systems for
the National Unused and Expired Medicines Registry and has determined that
JANUSINFO is appropriate and efficient in characterizing the relative potential
Safe Medicine Disposal for ME: A Handbook and Summary Report y April 2010

59

environmental risk and hazard of UEMs. The scientific basis of JANUSINFO follows
industry guidelines established by the U.S. Department of Health and Human Services,
U.S. Food and Drug Administration, and the Organization for Economic and Cooperation for Development (OECD). OECD is a 30-country membership body
established in 1961 to monitor, create standards, and present recommendations to help
governments foster prosperity and fight poverty through economic growth and financial
stability, as well as to ensure and address environmental implications of economic and
social development.

In general, the standards and recommendations for environmental risk and hazard
assessments are more stringent in Europe than those in the U.S. For more technical
information and description of these standards, refer to the publication Environmental
Classification of Pharmaceuticals.24

Environmental risk and hazard data point to the need for disposal program options and
communication campaigns that educate the public about the potential environmental
impact of drugs that have been disposed of improperly. Findings from the mailback
program indicate that, for drugs where environmental impact data were available, there
was at least some risk or hazard present among the returns. Approximately 43% of the
drugs collected were found to be a hazard to the environment and 50% of the returns
presented environmental risk.

Conclusions
Maine’s citizen mailback program has demonstrated that this approach is not only
feasible, but effective. The program utilized a phased implementation, beginning by
targeting elders and focusing on pharmacies as distribution sites for the mailback
envelopes. We then phased in a broader target population, adults of all ages, as well
as a broader range of distribution sites (other providers of health services).

24 Contact the Community Medical Foundation for Patient Safety for more information:
www.communityofcompetence.com
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The mailback envelope take-back method returned a large quantity of drugs that would
have otherwise been disposed of directly into the water system through flushing or into
landfills through the trash. A short survey inserted in the envelope allowed us to track
the reasons for participation, the sources of the drugs, and the demographic profile of
the participants. This is information that is useful not only for project planning and
education, but also policy development.

The mailback program provides a rich opportunity to educate a broad public citizenry
about prescription drugs and the environment via community outreach and information
distributed with the mailer. It involves citizens in an easy, “DIY” (do it yourself) problemsolving program that prevents environmental harm, prevents drug diversion, and
prevents poisoning. Community education by older adults was found to be both effective
and engaging while encouraging new users of the program to spread the word in their
local communities. It is for this reason the consumer involvement should be a key
component in any drug return program model.

The major challenge for this and other disposal programs continues to be funding to
sustain such efforts. All disposal programming, whether mailback or event-based
takeback programs, require a considerable amount of time and effort to plan, execute,
and educate the public. Our first two phases have shown us that the interest and the
community need exist and in fact, clearly outweigh the resources available to address
the issue of drug disposal. However, it is imperative to continue as many programming
and outreach efforts as possible to provide drug disposal options directly to the
consumer at the same time that information is disseminated so as to avoid the
confusion and misinformation the surrounds the issue of drug disposal.
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APPENDIX 1
Safe Medicine Disposal for ME
Contact Information
Daily operations:
Jennifer Crittenden, M.S.W.
Project Director
Research Associate
UMaine Center on Aging
jennifer.crittenden@umit.maine.edu
207-262-7923
Project administration:
Lenard Kaye, D.S.W./Ph.D.
Principal Investigator
Director and Professor
UMaine Center on Aging
len.kaye@umit.maine.edu
207-262-7922
Technical/Scientific issues:
Stevan Gressitt, M.D.
Co-Principal Investigator
Medical Director, Adult Mental Health Services
Maine Department of Health and Human Services
stevan.gressitt@maine.gov
207-287-4273
General Project Information:
Phone: 1-866-ME-RX-RID (1-866-637-9743)
Email: info@safemeddisposal.com
Website: www.safemeddisposal.com
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APPENDIX 2
Project Collaborations/Partnerships
and Leveraged Resources
Maine-Based Organizations
• Center on Aging, University of Maine
• Maine Association of Psychiatric Physicians
• Maine Benzodiazepine Study Group (MBSG) & Drug Disposal Group
• Maine Council for Child & Adolescent Psychiatry
• Maine Department of Health and Human Services
• Maine Department of Environmental Protection
• Maine Drug Enforcement Agency
• Maine Office of Adult Mental Health Services
• Maine Office of Substance Abuse
• Maine Center for Disease Control and Prevention
• Maine Office of the Attorney General
• Maine Office of Elder Services
• Maine Pharmacy Association
• Independent pharmacies throughout Maine
• Maine Retired Senior Volunteer (RSVP) Programs
• Margaret Chase Smith Center Policy Center, University of Maine
• Northern New England Poison Center
• Husson University School of Pharmacy
• University of New England
• Maine Medical Association
• Safe Medicine for Maine
Federal & National Organizations
• American Pharmacists Association
• Community Medical Foundation for Patient Safety
• National Council on Patient Information and Education
• Office of the U.S. Attorney General
• Rite Aid Corporation
• CVS Pharmacies
• U.S. Drug Enforcement Administration
• U.S. Environmental Protection Agency Aging Initiative
• U.S. Postal Service
• Villanova University Center for the Environment
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APPENDIX 3
Project Timeline: Phases I & II of Pilot
•

Create consolidation, transportation, and incineration protocols

•

Commence meetings of technical advisory task force

•

Secure network of 75 distribution points (pharmacies) to which mailers are
distributed in both phases

•

Engage community advisory board members

•

Commence meetings of community advisory board

•

Design and create mailers and accompanying survey, training materials
for Distribution Site Educators and instructions for pharmacies and public

•

Create web site, establish 800 number call center and create related
training materials and protocols

•

Engage and train Distribution Site Educators

•

Develop education campaign content and communication dissemination
plan

•

Launch Phase I education campaign

•

Distribute informational materials for pharmacists, staff, and individuals
acquiring mailers for Phase I; provide training

•

Collect, inventory and destroy returned products in compliance with
applicable state and federal laws and sound environmental practices in
four-county region for Phase I

•

Contract with incineration facilities and transportation contractors

•

Evaluate Phase I and refine for Phase II

•

Launch Phase II education campaign

•

Distribute informational materials for pharmacists, staff, and individuals
acquiring mailers for Phase II; provide training

•

Collect, inventory and destroy returned products in compliance with
applicable state and federal laws and sound environmental practices
statewide for Phase II

•

Generate, analyze and report on survey and inventory data in a manner
that allows physicians, pharmacists, insurance companies, patients and
others to modify behaviors to minimize unused medications

•

Conduct final evaluation of project

•

Publish best practices guidebook
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APPENDIX GROUP 4
Contextual and Technical Documents
•

APPENDIX GROUP 4: Contextual, legal and technical documents and
agreements that link the project with the following:
o APPENDIX 4A: 2003 Drug Disposal Group meeting minutes‐Legislation
development for disposal program
o APPENDIX 4B: Final report of the Maine Drug Return Implementation Group
established through LD 1826
o APPENDIX 4C: U.S. Drug Enforcement Administration Program Review Letter
o APPENDIX 4D: U.S. Postal Service and Maine Drug Enforcement Agency Test
Agreement document
o APPENDIX 4E: Northern New England Poison Center Medication Disposal
Summary
o APPENDIX 4F: Maine Medicaid program: summary of 15‐day prescription
policy
o APPENDIX 4G & 4H: 2007 and 2008 Proper Drug Disposal Day Proclamation
issued by Maine Governor John Baldacci
o APPENDIX 4I: Athens Declaration and Istanbul Statement
o APPENDIX 4J: Ruhoy and Gressitt paper abstract on reasons for drug disposal
o APPENDIX 4K: Postal Service press release on VA mailback program in
Baltimore, Washington, DC, and West Virginia
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Drug Disposal Group
Interested Parties Meeting
December 16, 2003

Attached is the attendance list.
Introductory Remarks
Senator Lynn Bromley opened the meeting at 10am. She noted that her goal was to pass
a bill on this issue, hoping to come out of today’s meeting with an outline. Her deadline
for drafting legislation is January 6 at the Revisor’s Office. Let’s not make perfect the
enemy of the good, she suggested.
The group represented a wide variety of constituencies and viewpoints. As individuals
introduced themselves and stated their reasons for attending the meeting, Senator
Bromley noted the priority categories into which they fell. Seven said they were here for
diversion issues, nine regarding waste issues, five for education, three for mistaken
prescriptions, and two for security issues.
Karen Simone from the Poison Center noted that the center would support anything
environmentally sound, as they used to recommend flushing because of the speed with
which you could get rid of it. She noted that garbage cans are not safe for kids and are
often raided by drug abusers. We need to make sure we’re not making these drugs more
accessible.
Many members of the state’s environmental community, including the state’s fish
pathologist, biologist, as well as the state geologist, attended and raised concerns
regarding the impact of drug disposal on groundwater. They noted that a lot of work is
being done on the downstream effects of flushing prescription drugs. Ann Pistell of the
DEP said that they deal a lot with product stewardship issues, which has a role in this
discussion. Scott Austin of the DEP noted that he deals with hospitals on this issue and
that there are no hospital incinerators left in Maine.
We were joined by Laurie Tenace of Florida who is working on this issue regarding
pharmaceuticals and personal care products. She is scheduling a teleconference on this
issue in January.
The Rite-Aid representative noted that we need to find out what the Federal regs were for
scheduled drugs and that an appropriate method for paying for this needed to be found.
Marci Sorg, from the Margaret Chase Smith Center, was involved in the drug
mortality/morbidity studies recently and works with the state medical examiner. She has
seen the results of a lot of mistakes, especially in the elderly.

Ann Robinson, representing Pharma, noted that diversion is an issue with today’s
children, stressing that drugs ought to be taken by those to whom they were prescribed.
The science issues are complex and emerging with lots to be learned. She advised the
group to proceed with caution.
Jim Cameron from the Maine Attorney General’s Office is concerned about diversion,
noting that Schedule II drugs have a huge street value. A collection mechanism must
keep this in mind. Security must be built in.
Pharmacies, represented by both Jim MacGregor of the Maine Merchants Association,
and Bob Morisette, noted that reverse distribution is a common practice.
Current Practices
Scott Austin noted that there are some current requirements, including RCRA, which
controls toxic drugs (chemotherapy, etc) and the DEA, which dictates controlled drug
disposal. He noted the need to involve the State Board of Pharmacy. The Maine
Hospital Association has identified alternatives to incineration. Scott noted that there
would be some pollution concerns. Steam sterilization is a cleaner non- incineration
option for waste but not for drugs.
It was noted that law enforcement incinerates at 1800 degrees. They incinerate evidence,
both pills and marijuana, totaling 9.1 tons per year. This is mostly marijuana. It was also
noted that chemo drugs cannot be incinerated.
Ann Pistell noted that the USGS has identified pharmaceuticals in the water. The EPA is
doing a sampling and we should have results by the end of the month.
Suggestions for Legislation
Dr. Gressit told the group that the DEA has said that controlled drugs cannot be returned
to pharmacies and other providers. Apparently specific licensed individuals cannot
handle these as returns. He suggested a mail-back program where a packet would go to
the post office and the DEA could empty the box and dispose of the contents
appropriately.
Ann Pistell suggested considering product stewardship. The returns could go back to the
pharmaceuticals, similar to the mercury switch law. She also suggested that perhaps they
could be handled as hazardous waste and be collected as such. The group discussed this
but concerns over the safety of handling the drugs were prevalent.
Marci Sorg cautioned the group to consider HIPPA issues.
Senator Bromley threw out the idea of doing a pilot program with one drug but the idea
was dismissed. All prescription drugs would be preferable.
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The group agreed that incineration would be worth pursuing. However, the “air people”
at DEP need to be able to weigh in on this. Extra manpower and resources would be
needed for this. Having the DEA incinerate would satisfy the licensing question.
The DEP suggested that Maine needs better waste control treatment plants, which should
be the subject of a separate bill.
Roy McInney of the MDEA had a number of comments. 1) From a public safety
standpoint, the MDEA would like to be of assistance, as long as it does not endanger its
core mission, which is to reduce the drug supply through identification and prosecution of
drug traffickers. 2) MDEA has a central evidence facility, which has 5000 individual
exhibits collected each year. They dispose of these through incineration. Approx 9 tons
were destroyed last year. 3) We must find funding for using MDEA’s infrastructure. It’s
$88/ton for destruction. And the cost of staff needs to be covered. They would need two
people and a vehicle to do this. Roy was interested in finding out how much volume
we’re expecting but this number was too hard to discern (somewhere between 5000 and
10000 pounds was suggested).
The public health nurse asked the group what they thought of including veterinarian
medications. The group seemed interested and agreed to include them.
Focusing the Legislation
Senator Bromley suggested that the legislation be a pilot program. Marci Sorg was
solicited to suggest particular counties where diversion was the worst and she
recommended Cumberland and Washington. However, Anna Bragdon suggested that we
ask for a statewide program and only reduce it to a pilot program if need be.
Dr. Gressit suggested using school districts to distribute information and mailers.
Marci Sorg suggested that there may be federal dollars and money from drug
manufacturers. Jim Cameron noted that the manufacturers have foundations. We would
need to determine how we would use the money before we asked. It’s important to have
no strings attached. He suggested Purdue Pharma and Phizer.
It was suggested that we poll the state for current disposal behaviors. There is a
statewide survey already done which we could add a question to for a fee. It is sent to
4000 Maine residents.
The group discussed doing a random opening of 100 packages to learn from them. We
could translate found pills into actual dollars. The Poison Center could do the research
on the pills with some staff help. There may be privacy issues that need to be addressed.
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Issues needing further attention
Postal inspectors
Liquids
Committee referral – HHS
Mobilization of support (including AARP)
Research aspect
Rules should be minor technical.
Conclusion
Senator Bromley wrapped up the meeting by reviewing the group’s progress. A bill will
be drafted which will call for mailers for returned prescriptions to be destroyed by the
MDEA. It will include veterinary meds and the rules will not be major substantive.
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Northern New England Poison Center
Medication Disposal Summary Report
Latest update (1/17/2008)
Purpose
The purpose of this report is to:
• Summarize research related to, and the controversy surrounding, medication disposal.
• Document rationale for the Northern New England Poison Center’s (NNEPC)
Medication Disposal Recommendation.
Executive Summary
Medication-related overdoses have increased significantly in recent years. 1 Limiting access to
medicines is a key prevention strategy (“clean out the medicine cabinet”). 2
Pharmaceuticals and other personal care products (PPCP) have been found in our water
supply. 3 The sources are most likely excrement, flushed products and ground water
contamination from land-fills. 4, 5, 6, 7 The presence of PPCP in the environment has not been
proven to negatively affect humans. However, the health effects from long-term exposure to
these compounds are not clear. 8
There is controversy about how to properly dispose of medicines (Table 1 & 2). 9 There are
three common methods utilized throughout the United States for medication disposal: flushing,
throwing away and collecting5,10,11 All of these options have strengths and weaknesses.
Legislation related to medication reuse and disposal varies by state. The goal of any disposal
method needs to keep these in mind:
 Prevent acute poisoning;
 Prevent abuse;
 Ensure patient safety;
 Limit environmental impact and water supply contamination.
Ultimately, any disposal recommendation needs to be practical, cost effective and safe. The
NNEPC is taking an active role in developing disposal recommendations for the general public
and health care and public health professionals.
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Call to Action
In 2006 the American Medical Association (AMA) passed a resolution asking the United States
Environmental Protection Agency (EPA) to lead the nation in addressing this issue. The AMA
requested that the EPA:
1. Continue aggressive research to understand the public health impact of PPCP’s on the
drinking water supply, environment and human health.
2. Lead and engage stakeholders from other federal agencies, the pharmaceutical
industry, hospitals and other health care institutions, health professional organizations
representing physicians, pharmacists, and nurses and the public for the proper disposal
of PPCP to prevent drinking water contamination and environmental impact. 12
Medicine-Related Poisonings
Childhood poisonings - In 2005, in the United States, more than a half-million calls were made
to poison centers about medication-related poisonings among children 5 years of age and
younger. 13
Medication overdoses - In 2004, poisoning became the second leading cause of death from
unintentional injury in the United States. According to the Centers for Disease Control and
Prevention, nearly all poisoning deaths in the United States are attributed to drugs, and most
drug poisonings result from the abuse of prescription or illegal drugs.1 Several reports confirm
this alarming trend of pharmaceutical abuse and misuse. 14,15,16,17,18
Pharmaceuticals and Personal Care Products (PPCP) in the Water Supply
Medicines are not entirely absorbed by our bodies, and are excreted and passed into
wastewater and surface water. According to the Environmental Protection Agency, studies
have shown that pharmaceuticals are present in our nation’s waterbodies.3-7 Research
suggests that certain drugs may cause harm to the environment. To date, scientists have not
found evidence of adverse human health effects from PPCP’s in the environment.8
Medications’ effects on the aquatic environment:
• Ability to resist degradation in the aquatic environment;
• Accumulation in adipose tissue of aquatic organisms;
• Potential to poison aquatic organisms. 19
It is important to remember, “Not everything that counts can be counted and not everything
that can be counted counts.” – Albert Einstein 20
Medication Disposal Recommendations
There is no undisputed recommendation for disposing of medicines (Table 1 & 2). There are
three common methods utilized throughout the United States for medication disposal: flushing,
throwing away and collecting for incineration. Community-based studies show that most
people dispose of unwanted medicines in their garbage or by flushing them down their toilets
or sinks, but would be willing and interested in properly disposing of their unused or expired
medicines by returning them to a convenient location (such as a pharmacy).5, 9-11,21,22
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Table 1. Comparison of Medication Disposal Recommendations

Strength

Flushing
medicine
down the
sink or
toilet

Pharmacy
take-back
programs

Hazardous
waste
management

√

√

√

√

√

√

√

√

Prevents children and pets
from unintentional
poisonings
Prevents drug users access
to medicines
Low impact on the
environment
Relatively inexpensive for
the participants and
communities
Population in support
Convenient

√

Weakness

Take-back
incineration
programs

Pharmacy
take-back
programs

Hazardous
waste
management

√

√

√

√

√

√

√

√

√

Costly
Inconvenient for
participants
Not available in all
communities
Where available, it is
infrequent and may lead to
hording (e.g., storing of
medicines for once a year
disposal could lead to
poisonings or drug
diversion)
Inconsistent disposal
practices among
pharmacies
Potential risk of
unintentional poisonings of
children and pets
Potential risk of access to
medicines for drug users
Increases the amount of
medication in our water
supply and environment
Not allowed to accept
controlled substances

Throwing
away
medicines
in the
garbage

Take-back
incineration
programs

√

√

√

√

√

√
Throwing
away
medicines
in the
garbage

√
Flushing
medicine
down the
sink or
toilet

√

√

√**
√
√

√^

√**

√**

√^

√

√**

√

** This may lead to an increase in the water supply, depending on how material is discarded.
^ Depends on state laws and regulations.
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Table 2. Various Agency Recommendations
Federal Agency

American
Pharmacists
Association

US Fish and Wildlife
Services

Medication Disposal Recommendation

Website

Crush solid medications or dissolve them in water (this applies for
liquid medications as well) and mix with kitty litter or sawdust (or
any material that absorbs the dissolved medication and makes it
less appealing for pets or children to eat), then place in a sealed
plastic bag BEFORE tossing in the trash.
Remove and destroy ALL identifying personal information
(prescription label) from the medication container.
Check for approved state and local collection programs or with
area hazardous waste facilities. In certain states, you may be able
to take your unused medications to your community pharmacy.

http://www.pharma
cist.com/AM/Temp
late.cfm?Section=
Public_Health2&T
emplate=/CM/HTM
LDisplay.cfm&Con
tentID=11650


Environmental
Protection Agency

Department of Health
and Human Services
American Medical
Association

Office of National
Drug Control Policy

Take unused, unneeded, or expired prescription drugs out
of their original containers and throw them in the trash.
 Mix prescription drugs with an undesirable substance,
such as used coffee grounds or kitty litter, and putting
them in impermeable, non-descript containers, such as
empty cans or sealable bags, will further ensure the drugs
are not diverted.
 Flush prescription drugs down the toilet only if the label or
accompanying patient information specifically instructs
doing so.
 Take advantage of community pharmaceutical take-back
programs that allow the public to bring unused drugs to a
central location for proper disposal. Some communities
have pharmaceutical take-back programs or community
solid-waste programs that allow the public to bring unused
drugs to a central location for proper disposal. Where
these exist, they are a good way to dispose of unused
pharmaceuticals.

Substance Abuse
and Mental Health
Services
Administration

• Mix unused drugs with coffee grounds, kitty litter, or another
undesirable substance and place in a sealed container before
disposing in the trash.
• Prescription drugs should not be flushed down the toilet unless
specifically instructed to do so.
• Where community prescription drug take-back programs exist,
they are a good way to dispose of unused pharmaceuticals.

Food and Drug
Administration

Throw away expired medicines at a home hazardous waste
disposal site or in a garbage can away from small children and
pets.

Centers for Disease
Control

Return to the pharmacy

http://whitehousedr
ugpolicy.gov/drugf
act/factsht/proper_
disposal.html

http://jama.amaassn.org/cgi/conte
nt/full/297/12/1307
-a

http://www.samhsa
.gov/rxsafety/SAM
HSA3tagged.pdf

http://www.fda.gov
/medsinmyhome/M
IMH_as_they_gro
w.htm
http://www2a.cdc.g
ov/podcasts/media
/pdf/EID%20Podca
st%2010-1806%20Antimicrobi
als%20Transcript.
pdf

5 of 6
American Association
of Poison Control
Centers

Under review

www.aapcc.org

Continue Table 2.
State Agency

Medication Disposal Recommendation
A. Voluntary Turn-In Events
B. Mail-In Program
C. Product Stewardship
D. Legislation to Consider Redistribution

Maine Department of
Environmental Services
Maine Department of Health
and Human Services

Website
http://www.umain
e.edu/mainecent
eronaging/docum
ents/globalperspe
ctives.pdf

Maine Pharmacy Association

Under review

www.mparx.com

New Hampshire Department
of Environmental Services

Contact your local household hazardous waste
coordinator prior to a collection event to determine if your
municipality will accept the waste. Most collection events
will accept mercury-added or other personal care
products, but not pharmaceutical waste.
Dispose of the waste in household trash.
Keep products in their original containers. Pharmaceutical
container caps are typically watertight and child proof.
Add a small amount of water to a solid drug or some
absorbent material such as kitty litter, sawdust or flour, to
liquid drugs before recapping to discourage any
unintended use of the drug.
Double seal the container in another container or heavy
bag to prevent easy identification of the drug container

http://www.des.st
ate.nh.us/factshe
ets/sw/sw-33.htm

New Hampshire Department
of Health and Human
Services

New Hampshire Pharmacy
Association

Crush solid medications or dissolve them in water (this
applies for liquid medications as well) and mix with kitty
litter or sawdust (or any material that absorbs the
dissolved medication and makes it less appealing for pets
or children to eat), then place in a sealed plastic bag
BEFORE tossing in the trash.
Remove and destroy ALL identifying personal information
(prescription label) from the medication container.

•
Vermont Department of
Health

•

Take unused, unneeded or expired prescription
and over-the-counter drugs out of their original
containers.
Mix the prescription drugs with an undesirable
substance (for example, used kitty litter, coffee
grounds, bacon fat, soil), place the mixture into a

http://whitehouse
drugpolicy.gov/ne
ws/press07/0220
07.html

http://healthverm
ont.gov/adap/ada
p.aspx

6 of 6
sealable plastic bag or container, and place it into
the trash.
•

Vermont Pharmacy
Association

When discarding a transdermal patch, fold the
patch into itself and then place it in the
undesirable mixture.
Under review

www.vtpharmacis
t.org
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Stevan Gressitt, M.D., Medical Director
Office of Adult Mental Health Services
Department of Health and Human Services
Marquardt Building, 2nd Floor
11 State House Station
32 Blossom Lane
Augusta, ME 04333-0011
Ph: (207)287-4273
Fax: (207)287-1022
Cell Phone: (207) 441-0291
E-Mail : stevan.gressitt@maine.gov
http://www.maine.gov/dhhs/mh/

Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s). It may contain confidential and privileged
information. Any unauthorized review, copy, use, disclosure, or distribution is prohibited. If you are not the intended recipient, please note that any
dissemination, distribution or copying of this is strictly prohibited. Please contact me by reply e-mail or telephone and destroy all copies of this message.
The Department of Health and Human Services (DHHS) does not discriminate on the basis of disability, race, color, creed, gender, sexual orientation, age, or
national origin, in admission to, access to, or operations of its programs, services, or activities, or its hiring or employment practices. This notice is provided as
required by Title II of the Americans with Disabilities Act of 1990 and in accordance with the Civil Rights Act of 1964 as amended, Section 504 of the
Rehabilitation Act of 1973, as amended, the Age Discrimination Act of 1975, Title IX of the Education Amendments of 1972 and the Maine Human Rights Act
and Executive Order Regarding State of Maine Contracts for Services. Questions, concerns, complaints or requests for additional information regarding the ADA
may be forwarded to DHHS’ ADA Compliance/EEO Coordinators, 11 SHS-221 State Street, Augusta, Maine 04333, 207-287-4289 (V), 207-287-3488 (V), 1-800606-0215 (TTY).

From: provider-bounces@informe.org [mailto:provider-bounces@informe.org] On Behalf Of Provider Notification
Sent: Friday, July 31, 2009 3:59 PM
To: List Serve
Subject: [Provider] 15-day limit on first-time prescriptions for certaindrugs

MaineCare has begun instituting measures to ensure cost effectiveness through the use of Drug Benefit
Management, Drug-Drug editing to ensure education and patient safety, recent PPI limitations and Intensive
Benefit Management with controlled substances.
For a number of years in Maine, research from the Maine Benzodiazepine Study Group, The University of Maine
Center on Aging, and in part funded by the only Federal Grant in the US on unused drug return mail back
programming has suggested that adherence to medication and other variables may lead to large amounts of
unused and discarded medication. Closer evaluation of side effects and efficacy may lead to better patient
outcome and better safety for patients with closer evaluation of initial response.
With that, MaineCare will institute new 15 day limits on initial prescriptions for various medication that have
been identified with high side effect profiles, high discontinuation rates, or frequent dose adjustments to ensure
cost effectiveness without “wasting” or “discarding” of used medications. Effective 8/6/09 MaineCare will begin
limiting initial prescriptions on the following medications, Suboxone, Subutex, Chantix and Nicotine replacement
products to 15 day supplies. Initial prescriptions for preferred products over the initial 15 day supply will require
prior authorization. Subsequent refills of these products will be allowed at the usual MaineCare allowable days
supply.
For further questions please contact Goold Health Systems at 1-888-4450497.
Is your mailing address up to date with MaineCare? Please keep MaineCare up to date so your Remittance Statements
and checks arrive on time. Call Provider Enrollment at 1-800-321-5557 Option #6.
If you would rather not get these e-mails, visit MaineCare's List Serve Subscription page to unsubscribe.
This is a one-way communication. Do not reply to this e-mail. Your e-mail will not receive response. If you have questions,
please call 1-800-321-5557.

file://C:\Documents and Settings\Jen\Local Settings\Temp\fcctemp\Attach0.html

9/23/2009

THE ATHENS DECLARATION as unanimously voted on August 3rd,
2007 at the 2nd International Conference on Environment in the City
of Athens Cultural Center is as follows:
We, an international group, support the following six reasons to address citizen unused
drug disposal:
1.
2.
3.
4.
5.
6.

To
To
To
To
To
To

curtail childhood overdoses
restrict household drug theft
limit accumulation of drugs by the elderly
protect our physical environment
restrain improper international drug donations
eliminate waste in the international health care systems of all countries

We call upon governments, NGO's, and citizens everywhere to correct policies and
practices that foster waste in the health care systems of all countries and endanger
humans, animals, and our physical environment.
We call upon all countries to renew their support of WHO Guidelines on Drug Donations
and the WHO Guidelines on Drug Disposal, and strive to improve on these.
We call upon health care providers worldwide to appropriately prescribe medicines to
patients in the most effective form and quantity.
We call upon health care organizations to refrain from policies that promote excessive
dispensing.
We call upon patients worldwide to recognize the need for medicine to be taken as
intended if it is to be effective.
We call upon governments, NGO's, and citizens worldwide to refrain immediately from
improper drug donations either as humanitarian aid following disasters or in general
practice.
We call upon others to endorse these principles with us for the betterment of the health
of the environment and patients worldwide.

Athens,
Greece
August 3rd,
2007

In North America:
Maine Benzodiazepine Study
Group
Stevan Gressitt, M.D.
207-441-0291
Gressitt@uninets.net
www.mainebenzo.org

Whereas inattention to prescribing policy, reimbursement incentives, formulary
selection, distribution, pricing systems, dispensing and actual prescription writing, have
led to the need for this Istanbul Statement of September 7, 2009 during the 69th
Conference of FIP. Confirming the Athens Declaration of 2007, this Statement as well
draws attention to responses to these problems in the Netherlands, Sweden, and the
State of Maine in the United States of America. Research from a number of countries as
diverse as Canada and Kuwait demonstrate the need for further work and research but
already a need for addressing the problem.
We thereby ask that all NGO's, governmental bodies, health care professionals,
pharmaceutical manufacturers, and citizens everywhere place unused drug disposal
and prevention of pharmaceutical waste as a highest priority. We encourage those
listed above to move to address this problem as soon as possible.

Istanbul, Turkey
September 7, 2009
Stevan Gressitt, M.D.

Rationale for a Concerted Focus on Unused
Pharmaceuticals
Ilene S. Ruhoy, MD
Doctoral Candidate
University of Nevada, Las Vegas
Department of Environmental Studies
Stevan Gressitt, MD
Maine Benzodiazepine Study Group, The Drug Disposal Group,
Medical Director, Northeast Occupational Exchange,
Corresponding Author: 314 Clark Road, Unity, Maine, 04988 207-441-0291
gressitt@uninets.net
Abstract:
Unused and unwanted consumer pharmaceuticals have a negative impact on
public health. The lack of effective and efficient methods of drug disposal has resulted in
unwelcome social, cultural, ecological, and global effects.
Among the many issues pertinent to unused consumer medication, we have
comprehensively explored and addressed six specific and significant problems;
1)
2)
3)
4)
5)

6)

Childhood Poisoning: Unintentional pharmaceutical poisonings of children,
resulting in unnecessary morbidity and mortality.
"Pharming": Theft and social use, misuse, and abuse of pharmaceuticals by
teenagers, adults, and older adults.
Excessive Accumulation and Polypharmacy: Polypharmacy, non-compliance
and/or poor adherence to medication regimens, and medication errors
contributes to accumulation and poor patient outcome.
Unintended Environmental Exposure: Potential deleterious effects on wildlife and
humans due to drug deposition in surface and ground waters as a result of
both disposal and excretion pathways.
Inappropriate Humanitarian Drug Donations: Under-regulated and poorly
controlled methods of international donations to countries in need, resulting in
massive amounts of “gifts” of unused and expired pharmaceuticals. Expired
and unwanted drugs ultimately become accumulated waste, some of which
may be hazardous, due in part to the lack of an environmentally sound
disposal or destruction method.
Pharmacoeconomics: Unused medications contribute to wasted health care
dollars. The purchase costs of drugs to the consumer, the insurance carrier, and
the taxpayer have continued to increase in the past decade.

These issues define the problem of proper disposal of unused pharmaceuticals
and beg for acceptable solutions to protect human and environmental health.

FOR IMMEDIATE RELEASE
April 8, 2010

Contact: Darlene Casey
(O) 202-268-3440
darlene.casey@usps.gov
usps.com/news
Release No. 10-032

Postal Service Expands Prescription Mail Back
Program Diverts Expired, Unused Medicine from Landfills, Water Supply
WASHINGTON — Veterans will be able to safely dispose of expired and unused prescriptions and help the
environment at the same time under a program offered by the U.S. Postal Service and U.S. Department of
Veterans Affairs (VA).
This pilot program is limited to an estimated 780,000 veterans living in Baltimore, Washington, DC, and West
Virginia. Veterans mail back outdated, unwanted medicine. Federally approved facilities safely destroy the
medicine, insuring that prescriptions don’t end up in municipal refuse, soil or ground water.
“This initiative pairs the convenience of the mail with the safety of a federally approved prescription drug
disposal process,” said Robert Bernstock, president, Mailing and Shipping Services. “The Prescription Mail
Back program demonstrates the Postal Service’s continued value as an integral part of American
communities.”
Veterans receive specially designed, postage-paid envelopes and instructions with their prescription
fulfillment. Expired and unused pharmaceuticals placed in the special packaging can be dropped in familiar
blue USPS collection boxes or at Post Offices. The envelopes are delivered to facilities regulated and
approved by the Environmental Protection Agency (EPA) and Drug Enforcement Agency (DEA).
Pharmaceuticals from this and other similar mail-back initiatives are destroyed in accordance with EPA and
DEA standards, including cataloguing and use of incineration, chemical or thermal processes.
The prescription mail-back initiative began in the state of Maine in 2008, and has been successfully
expanding ever since. The VA program joins similar ones in 47 states. Mail-back envelopes are being
distributed at supermarket pharmacies, in doctors and dentists offices, and at medical facilities including
hospitals, clinics and hospices.
th

“The 40 anniversary of Earth Day is a perfect opportunity to tell Americans the good news about the
expanded prescription mail-back program,” said Sam Pulcrano, vice president, Sustainability. “It is another
way the Postal Service demonstrates its commitment to the environment.”
The Postal Service has won more than 75 environmental awards, including 40 White House Closing the
Circle, 10 Environmental Protection Agency WasteWise Partner of the Year, Climate Action Champion, Direct
Marketing Association Green Echo, and the Postal Technology International Environmental Achievement of
the Year, 2009.
For more information about the Postal Service green initiatives, tools and products, visit usps.com/green.
The Postal Service receives no tax dollars for operating expenses, and relies on the sale of postage,
products and services to fund its operations.
###
Please Note: For broadcast quality video and audio, photo stills and other media resources, visit the USPS Newsroom at
www.usps.com/news.
A self-supporting government enterprise, the U.S. Postal Service is the only delivery service that reaches every address in the nation,
150 million residences, businesses and Post Office Boxes. The Postal Service receives no direct support from taxpayers. With 36,000

retail locations and the most frequently visited website in the federal government, the Postal Service relies on the sale of postage,
products and services to pay for operating expenses. Named the Most Trusted Government Agency five consecutive years and
the sixth Most Trusted Business in the nation by the Ponemon Institute, the Postal Service has annual revenue of more than $68 billion
and delivers nearly half the world’s mail. If it were a private sector company, the U.S. Postal Service would rank 28th in the 2009 Fortune
500.
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Phase II Area Agency on Aging Recruitment Letter

October 1, 2008

Dear AAA Director,
The Safe Medicine Disposal for ME Program is a program that provides postage-paid envelopes
to Maine residents for safe disposal of unused and unwanted medicine. During the past year, the
Safe Medicine Disposal for ME Program has been working to establish pilot program sites
within a designated four-county area. The program has become such a success within our pilot
pharmacy sites that we are now expanding the program statewide. Our first key step is to secure
partnering distribution sites across the state that are interested in providing Maine residents with
pre-paid envelopes for medicine disposal.
We would like to extend an invitation for your organization to join a growing roster of
organizations that are participating as a distribution site for envelopes. As an Area Agency on
Aging, you and your staff members represent a critical link to older adults throughout the state.
Research indicates that older adults consume far more prescription drugs than any other
population, putting them at risk for accumulation of medication that is unneeded and unwanted.
Please consider joining our program as a distribution site. Here is what is required of distribution
sites:
o There is no cost to you or to program participants (this is currently a grant-funded program).
o A designated staff person at your location should provide program envelopes to all interested
individuals at no cost to them.
o You will be asked to display a sign or flyer at your location alerting the public to the
availability of program envelopes.
o You and your staff do not need to answer any questions about the program. We have an
established Program Helpline for participants.
We anticipate that envelopes will be available for distribution within the next few months.
Please confirm that your organization is interested in participating in the program. If you are
interested in serving as a site, please complete the attached contact information sheet to ensure
that we have up to date contact information for you and your site. Return this form to me by email at: jennifer.crittenden@umit.maine.edu or by fax at 207-262-7921. You can expect to
receive regular updates on the program as we gear up to go statewide.

Thank you for considering partnering with our program. We hope that you will consider serving
as a site for this very important project benefiting Maine residents. Please do not hesitate to
contact me with any questions you may have.

Sincerely,

Lenard Kaye, DSW/Ph.D.
Principal Investigator

Jennifer Crittenden
Program Director

Safe Medicine Disposal for ME Program

March 16, 2010
To: Safe Medicine Disposal for ME Site Contacts
From: Jennifer Crittenden, Program Director
RE: Welcome to the Safe Medicine Disposal for ME Program!
On behalf of the Safe Medicine Disposal for ME Program, we would like to welcome
your organization to our growing list of statewide mailback program sites. Our program
originally began in the spring of 2008 and was geared toward older adults. It has become
such a success that we are now expanding statewide and opening the program to all ages
(no longer just for older adults). We expect to be fully operational statewide by the end of
November.
Please take a moment to review the items in your welcome folder. These items include a
Procedure Guide, Question and Answer Guide, Detailed Fact Sheet, Program Site Listing,
Consumer Fact Sheet and a copy of the Memorandum of Understanding (MOU).
Along with the envelopes that have been provided to you, you will find a program sign
for display at your site along with consumer education materials related to the program.
Feel free to distribute these items as you see fit.
Welcome to the program and please feel free to contact the helpline with any general
questions or concerns you may have at 1-866-637-9743.
Thank you for your commitment to health and safety of Maine’s citizens.

Sincerely,

Jennifer Crittenden
Program Director

UNIVERSITY OF MAINE CENTER ON AGING • CAMDEN HALL
25 TEXAS AVE •BANGOR, ME • 04401
PHONE: 1-866-637-9743• WWW.SAFEMEDDISPOSAL.COM

Safe Medicine Disposal for ME Program

March 16, 2010

Dear NAME HERE,
Thank you for agreeing to participate in the next phase of the Safe Medicine
Disposal for ME program.
We will arrange for shipment of program envelopes and a welcome packet
directly to the address we have on file for your site. We anticipate that these will
be delivered to you in November.
Enclosed, you will find a copy of the program MOU. It outlines the basic
concepts and expectations of the program. Please sign this form and send it
back to the Center on Aging for our files either by mail at UMaine Center on
Aging, ATTN: Lynette Roy, Camden Hall, 25 Texas Ave., Bangor, Maine 04401
or by fax at 207-292-7921. Once we have this on file we will be able to arrange
for your envelope shipment.
Once again, welcome on board, and please feel free to contact the helpline with
questions or concerns at 1-866-637-9743.
Sincerely,

Jennifer Crittenden
Program Director

UNIVERSITY OF MAINE CENTER ON AGING • CAMDEN HALL
25 TEXAS AVE •BANGOR, ME • 04401
PHONE: 1-866-637-9743• WWW.SAFEMEDDISPOSAL.COM

SAFE MEDICINE DISPOSAL FOR ME PROGRAM
MEMORANDUM OF UNDERSTANDING
(WITH PARTICIPATING SITES)

This Memorandum of Understanding (MOU) contains basic provisions which guide the
working relationship between both parties. This MOU may be amended, in writing, at any
time with the concurrence of both parties and may be renegotiated at the end of Phase II of
the program.
PROVISIONS OF THE MEMORANDUM OF UNDERSTANDING
Safe Drug Disposal for ME Program:
•

The Program will arrange for drug return envelopes and materials to be mailed to your
site or corporate location.

•

The Safe Medicine Disposal for ME Program will have a hotline number for site
personnel and the public to call in order to ask questions or voice concerns. This is a
voice mail system staffed by the University of Maine Center on Aging. Messages will be
returned within 2 business days.

•

The Program will promote to the public all Phase II participating sites. Marketing
materials will include, when possible, the name of the participating pharmacy or site, the
physical location of the site, and the site telephone number.

•

There is no charge to sites or community members to participate.

Participating Sites:
•

All signage must be placed for the public to see, such as on the sales counter, in order to
indicate that project envelopes are available. Supplies of program brochures, consumer
fact sheets and business cards will be available for sites to distribute.

•

Envelopes are not to be provided to group homes, nursing homes, or other facilities for
their use. The Safe Medicine Disposal for ME Program is only available to individual
citizens at this time.

•

Envelopes are to be given free of charge to all who ask. No purchase is necessary.

•

Sites are not expected to answer questions regarding the program. Business cards with
program hotline contact information will be available for customers seeking further
information.

•

Sites are expected to use the program hotline if any questions or concerns should arise.

•

Sites agree to provide information on a regular basis concerning the number of envelopes
available when contacted by program staff.

•

Sites agree to proactively provide customers with drug return envelopes in order to
promote the program. This program is open to adults of all ages.

By signing and dating this Memorandum of Understanding, I acknowledge that I have read
and understand the above stated provisions, and agree to adhere to them as closely as
possible. I also agree that I am the primary contact for my site for all future communication
with the Safe Medicine Disposal for ME Program.
SITE CONTACT PERSON SIGNATURE: ____________________________________

DATE: __________

SITE CONTACT PERSON (PRINT NAME):___________________________________
PROGRAM STAFF MEMBER SIGNATURE: _________________________________
PROGRAM STAFF MEMBER (PRINT NAME):________________________________

DATE: __________

Is Your Home Safe?

If you have unused or expired medicine
in your home, you may be at risk of…
Theft of medicine by drug abusers
Poisoning of loved ones and pets
Taking expired or wrong medicine
Polluting your environment

Make your home safe by getting rid of
unwanted or expired medication though the
Safe Medicine Disposal for ME Program.

Free postage-paid
medicine return
envelopes available
here for all Maine
residents.
Ask a staff member for more
information.
Safe Medicine Disposal for ME Program

P ROGRAM Q UESTION AND ANSWER GUIDE

Safe Medicine Disposal for ME Program
What is Safe Medicine Disposal for ME?
Safe Medicine Disposal for ME is a program which provides an opportunity for
Maine residents to safely dispose of unused or expired medicine by mail.

What will I be asked to do?
Please ask your customers or clients if they would like an envelope to safely dispose of unused
or expired medicine in their home. If they are interested, give them an envelope with a survey
and directions inside. Please provide envelopes to anyone who asks for one. No purchase is
required and there is no cost to participate.
Who should get the envelopes?
When the program first began, it was specifically designed for older adults. However, the need
for safe medicine disposal affects many age groups. In response to this need, the program is
now designed for adults of all ages. The envelopes are for individual or family use only,
and are not intended for nursing homes, groups homes or other large group returns.
What about participants who want more than one envelope?
Participants may use more than one envelope. Please use your judgment when handing out
multiple envelopes. Supplies are limited. Once you run out of envelopes we cannot guarantee
that we can provide you with additional envelopes.
How much does it cost?
Nothing. There is no charge to the distribution sites or the participants for the postage-paid envelopes. Funding for this program was provided by the United States Environmental Protection
Agency’s Aging Initiative.
What do the participants do with the envelopes?
They enclose all unwanted medicine according to the Instruction Booklet included in each
envelope and mail the envelope just like any other letter or package. There is a Program
Helpline (1-866-637-9743) they can call if they have any questions.
Why are the envelopes numbered?
This is a code number for tracking the envelopes. Participants will call the Program Helpline at
1-866-637-9743 when they mail their envelope and leave only the code number and the date
that it was mailed (not their name) on the recording. The code number helps us to know which
envelopes to expect and how long they take to get to the Maine Drug Enforcement Agency for
storage and disposal.

What if we run out of envelopes?
Please contact the Program Helpline. Envelope supplies are limited and we cannot guarantee
that we will have additional envelopes for your pharmacy or organization.
Where does the medicine go?
The envelopes are returned to the Maine Drug Enforcement Agency. The medicine is then
cataloged and safely destroyed.
What happens to the surveys?
The confidential surveys are sent to the Maine Drug Enforcement Agency along with the medicine where they are then forwarded on to the University of Maine Center on Aging. The Center
will conduct an analysis to determine the types of medicine returned and the reasons for the
medicine being returned.
Will I be able to find out the results of this program?
Information about the amount and type of medicine that was returned will be posted on the program website as it becomes available.
What if I have additional questions or concerns about this program?
Please contact the Center on Aging (contact information below) with any questions or concerns
you may have.

Updated September 19, 2008
© 2008 University of Maine Center on Aging

Contact Information
If you have questions, please do not hesitate to contact us by e-mail or phone:
E-Mail at: info@safemeddisposal.com
Program Helpline at:1-866-673-9743
For more information about the program, visit:
www.safemeddisposal.com

Thank you for your participation and for your commitment to well-being of Maine’s
residents and our environment!

Safe Medicine Disposal for ME Program

SITE NEWSLETTER (March 10, 2009)
This newsletter is specifically designed for pharmacies, healthcare offices,
police departments and community agencies that are distributing envelopes
through the Safe Medicine Disposal for ME Program (mailback program)

Program Updates

Since the mailback program began we
have collected over 700lbs of medicine,
from over 1600 envelopes. About 10% of
the returned medicine is controlled
(narcotics).
The program went statewide and opened
to individuals of all ages (no longer just
older adults) in November 2008. We
have over 100 distribution sites that
include pharmacies, several police
departments and agencies. We also have
several more potential sites on a waiting
list.
The Helpline remains active receiving
messages from people who have mailed in
envelopes, have questions about the
program, and those who want to become a
distribution site.

Need more supplies?

If you need more envelopes, signs,
pamphlets, tip sheets or business cards
please leave a message on the Helpline, the
number is 1-866-637-9743.
We are currently out of envelopes but are
planning to get more in the coming
months. In the meantime we are putting

sites on a resupply list to receive envelopes
as soon as we get them.

Community Volunteers

We have several community volunteers
trained on the Safe Medicine Disposal for
ME Program. Volunteers are located in
Aroostook, Hancock, Kennebec, Knox,
Oxford, Penobscot, Piscataquis, and York
counties. If you would like a volunteer to
work with you on a disposal or
education/outreach event please contact
us and we can connect you with a
volunteer in your area.

How to Contact us:
Helpline: 1-866-637-9743
Website:
www.safemeddisposal.com
E-mail:
info@safemeddisposal.com
What happens to the medicine
that is returned?

All envelopes that are returned are
inventoried by pharmacists and pharmacy
techs. Medicine is then sorted for disposal
(incineration). See page 2 for pictures.

Page 1 of 2

Continuing Education Opportunity:
Save the Date!
2009 International Symposium on
Pharmaceuticals in the Home and
Environment

October 18-20, 2009
Point Lookout Resort and Conference Center,
Northport, Maine
Continuing Education Units (CEUs) will be
offered!
For more information visit:
www.mainebenzo.org/2009conference.htm

Unfortunately we receive many
bottles of unopened medicine
representing thousands of
wasted healthcare dollars.

Here are some interesting pictures
from our inventory sessions:

Cataloging in action

This is just a small sample of
what we have received

It is not uncommon to see older
medicines like this bottle of
Formaldehyde

Medicine that is mixed
together without a bottle as
shown here creates challenges
for sorting and identification.
Page 2 of 2

APPENDIX 6
Helpline & Volunteer Information
Staff and Volunteer Question & Answer Guide

Safe Medicine Disposal for ME: A Handbook y March 2010

A6

NOT

FOR

DISTRIBUTION: FOR

USE BY

PROJECT STAFF

AND

VOLUNTEERS O NLY

Safe Medicine Disposal for ME:
Staff and Volunteer Question and Answer Guide
What is Safe Medicine
Disposal for ME?
Safe Medicine Disposal for
ME is a program which provides an opportunity for individuals and families in Maine
to safely dispose of unused or
expired medicine by mail.

•
•
•

•

What are the benefits of
using this program?
Reduce the chances for
medication errors.
Keep medicine away from
children and pets.
Keep medicine away from
people who might misuse
it or steal it.
Dispose of medicine in a
way that protects Maine’s
environment.

Can I participate in this program?
The program is open to all individuals and families who have unused and unwanted medicine in need of disposal. The envelopes are for individual or family use only, and are not
intended for nursing homes, group homes, medical facilities, or other large group returns.
How much does it cost?
Nothing. There is no charge to the pharmacies distributing the envelopes or the participants returning medicine in the postage-paid envelopes. Funding for this program was
provided by the United States Environmental Protection Agency’s Aging Initiative.
Where can I get an envelope?
A listing of participating locations throughout Maine is available online at
www.safemeddisposal.com or you can e-mail info@safemeddisposal.com or call our
helpline for assistance at 1-866-637-9743.
Can you send me an envelope?
We are able to, on a limited basis, mail envelopes directly to individuals who are unable to
get to a participating pharmacy to obtain an envelope.
Can I use more than one envelope?
Yes, if all your medicine does not fit in one envelope you can use more than one envelope.
Please fill out a survey for each envelope that you mail.

Can I use my own envelope or box?
No. Please only use the special envelopes provided by the program. They have been approved by the US Postal Service for this purpose. If all of your medicine cannot fit into one
envelope, you may request additional envelopes from your nearest participating pharmacy
or via the program helpline.
What should I do with the envelope?
Enclose your unwanted or expired medicine according to the directions in the booklet
found in each envelope, then mail the envelope just like any other letter or package. You
can mail both liquids and pills in the same envelope as long as you follow the instructions
Or send an e-mail to:
info@safemeddisposal.com in the booklet provided. If you can’t find your instruction booklet, you can view a copy on
the program website or we can send you one by mail.
For general information about
What medicine can I dispose of through this program?
the program, log on to:
This
program
accepts
most kinds of prescription and over the counter medicine. Please do
www.safemeddisposal.com
not include more than a total of 4 ounces ( or 120mL) of liquids, creams, and/or gels.

How can I get more
information?
For technical questions,
please contact the University
of Maine Center on Aging
Program Helpline at:
1-866-637-9743

Is there any medicine that I can’t dispose of through this program?
Yes, some specialized medicine requires the use of a manufacturer disposal program.
Organization
Funding for this program was Check the packaging or contact your pharmacist for more information. Absolutely no syringes, medical devices (such as blood sugar monitors, etc.), needles,epi-pens broken
provided by the EPA Aging
glass, or sharp objects of any kind can be included. Even if they are wrapped or packaged,
Initiative.
they may not be included. Contact your doctor or pharmacist for disposal options for these
items.

Can I return medicine if it not in its original bottle?
Yes. Returning medicine in its original bottle will make it easier for pharmacist to identify it. However, if you cannot return it
in its original bottle, you can put in in a small container or zip lock bag before placing it in the envelope. Please write down
the name of the medicine, the dose, and the number of pills originally prescribed, if you know it.
Can I dispose of pet or veterinary medicine?
Yes, if there is room in your envelope after enclosing any prescription medicine you want to dispose of, you may include
pet or veterinary medicine. However, we recommend that you contact your local veterinary clinic, animal shelter, humane
society, or animal rescue group to see if they are able to use this medicine.
Can I dispose of over the counter medicine, herbal supplements, or vitamins?
Yes, if there is room in your envelope after enclosing any prescription medicine you want to dispose of, you may include
over the counter medicine, herbal supplements, or vitamins.
Can I dispose of medicated patches?
Yes. If the patches are not already in a wrapper, place them in a zip lock bag before placing them in the envelope.
Can I dispose of inhalers?
Yes, if there is room in your envelope after enclosing any other prescription medicine you want to dispose of, you may
include inhalers.
Will you be collecting information about me when I return my medicine?
Program staff will not be collecting any personal information about you from the medicine bottles that is returned. If you
wish, you may mark out personal information from the labels on your medicine bottles. Please do not mark over the name
of the medicine or number of pills. We will be collecting information only about the medicine that is returned in general to
better understand the amount and kind of medicine that is piling up in Maine medicine cabinets. Information that you provide on the survey will help us to understand this issue. The survey is confidential and you can skip any questions you do
not wish to answer.
Why are the envelopes numbered?
This is a code number for tracking the envelopes. Please call the Program Helpline at 1-866-637-9743 when you mail
your envelope and leave only the code number and the date that it was mailed (not your name) on the recording. The program is confidential, and any information about the returned medicine will not be linked to personal information. The code
number helps us to know which envelopes to expect and how long they take to get to the Maine Drug Enforcement
Agency for storage and disposal.
What if I mailed my envelope but forgot to write down the code number first?
Call the Program Helpline at 1-866-637-9743 and provide the date that you mailed the envelope and simply state that you
do you not know what the code number is.
Where does the medicine go?
The envelopes are returned to the Maine Drug Enforcement Agency. The medicine is then cataloged and safely
destroyed.
Do I need to fill out the survey in order to send in medicine?
You do not need to fill out the survey in order to participate in the program. The survey is optional. We encourage you to
consider providing a response to the survey because this research will help us to improve the program and to understand
why medicine goes unused in Maine.

What happens to the surveys?
The confidential surveys are sent to the Maine Drug Enforcement Agency along with the medicine where they are then
forwarded on to the University of Maine Center on Aging. The Center will conduct an analysis to determine the types of
medicine returned and the reasons for the medicine being returned.
Will I be able to find out the results of this program?
Information about the amount and type of medicine that was returned is available at http://www.safemeddisposal.com/
Research.php. You can also request this information by e-mail at: info@safemeddisposal.com or by calling 1-866-6379743.
I am a pharmacist. How can my pharmacy participate in the program?
Please call the helpline at 1-866-637-9743 and leave a message indicating you would like to become a site. A staff member will return your call and provide you with the paperwork necessary to become a site. As of April 2009 we are maintaining a waiting list for interested sites but we anticipate new sites will be welcomed to the program in the summer of 2009.

Updated April 23, 2009
© 2008 University of Maine Center on Aging

APPENDIX GROUP 7
Mailback Envelope Materials
•

APPENDIX Group 7: Participant Mailback Envelope Materials
o APPENDIX 7A: Instruction booklet for preparing and returning
medicine
o APPENDIX 7B: Informed consent for consumer survey
o APPENDIX 7C: Consumer survey

Safe Medicine Disposal for ME: A Handbook y March 2010

A7

Safe Medicine
Disposal for ME
Program
A program for all Maine
residents!
INSTRUCTION BOOKLET
Information on how to
prepare and return your
medicine for proper disposal
Helpline: 1-866-637-9743

Turn to view

2

1

Steps

9
No sharp objects or needles
9
No batteries, electronics, or medical devices (hearing
aids, blood sugar monitors)
9
No thermometers
9
Leave all medicine in the bottle/packaging
9
Containers with liquids, gels, or creams are to be wrapped in a
paper towel and sealed in a zip lock bag before you put them in the
envelope. Only 4 ounces (or 120 ml) total of liquids, gels or creams can be
mailed.

Place your unused medicine into the postage-paid envelope.

5 Step Quick Instruction Guide
Read through this booklet for information on the Safe Medicine
Disposal for ME Program.
**Keep this booklet. Do not mail it with your medicine.**
If you have questions, please call our Helpline: 1-866-637-9743

Safe Medicine Disposal for ME Program

S AFE M EDICINE D ISPOSAL
FOR

ME
P AGE 8

Program Partners

The program has been made possible by the
following organizational partners:

Please see back page for full listing of program partners

•

Hand the envelope directly to your mail carrier,

•

Bring it directly to your local Post Office for
mailing,

•

Place the envelope into a blue United States
Postal Service mailbox at your local Post
Office or other locations in your area, or

•

Place the envelope in your home mailbox.

Thank you for participating in this program! If you
have any further questions or comments about
the program please call:

1-866-637-9743
Please keep this booklet for your records.

Turn to view

Thank you for participating!
For more information:
Call: 1-866-637-9743
Visit: www.safemeddisposal.com

There are several choices available to you
including:

5

Mail the envelope as you would any other letter
or package through the U.S. Mail.

4

Mailing Your Envelope

Seal envelope and mail it. No postage is needed. Mail the postage-paid
envelope as you would any other letter or package through the U.S. Mail.

ME

Make a note of your envelope code number. It is a four
digit number located in the bottom left hand corner of
your envelope.
Write it here:__ __ __ __

FOR

3

S AFE M EDICINE D ISPOSAL

Complete the enclosed survey and place it in the envelope with
your medicine. DO NOT WRITE YOUR NAME ON THE
SURVEY OR PROGRAM ENVELOPE

P AGE 7

P AGE 1

S AFE M EDICINE D ISPOSAL

FOR

ME

S AFE M EDICINE D ISPOSAL

The Safe Medicine Disposal for
ME Program

ME

P AGE 6

Complete the survey
and place it in the
envelope with your
medicine.

Safe Medicine Disposal for ME is administered by the University of Maine Center on Aging
and Safe Medicine for Maine in partnership with
the Maine Drug Enforcement Agency, the Maine
Department of Environmental Protection, the
United States Postal Service, and many other organizations concerned about protecting the
health and welfare of Maine’s citizens. Because
our program partners are committed to your
health and safety, you are invited to take part in
this exciting new program. The program was created to give Maine residents a safe disposal option for unused and unwanted medicine.

FOR

If you have questions about what to put
into the envelope, please call the
Program Helpline at: 1-866-ME-RX-RID (1-866637-9743).
Visit our website: www.SafeMedDisposal.com
E-Mail: info@SafeMedDisposal.com

By mailing back your unused medicines, you:
⇒

Reduce your risk of taking medicine in error
that may be harmful or cause interactions with
other medicine

⇒

Reduce wasted healthcare dollars by
contributing to important research

⇒

Dispose of your medicine in a way that
protects Maine’s environment and prevents
groundwater contamination

⇒

Get unwanted medicine out of your home and
away from people who may want to steal your
medicine or take it illegally

Find the 5-digit code
number in the bottom left
hand corner of your
envelope.

Write it here and
keep for your records:__ __ __ __ __
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FOR

ME

P AGE 2

Where will my medicine go?
All medicine that you place in the pre-paid
envelope provided will be sent to the Maine Drug
Enforcement Agency for proper disposal.
How much does this cost?
Only a total of 4 oz (or 120ml) of liquids, gels,
and creams total can be mailed back. Wrap
them in paper towels, place them in a zip lock
bag, and put it in the envelope. Be sure to seal
the zip lock bag and envelope tightly.

There is no cost to you to participate. Postage
and disposal costs have been paid through
support from the Maine Drug Enforcement
Agency and other in-kind donations from
program partners.

Instructions
Liquids, Gels, and Creams
The total combined volume of all liquids, gels,
and creams returned should be 4 ounces
(about 120 ml) or less. Please wrap each
container of liquid, gel, or cream in a paper
towel and place it in a zip-lock bag before
placing them in the envelope with any other
medicine.
Once all your medicine is placed in the
postage-paid envelope, complete the survey
provided. Place your
completed survey in the
envelope and seal it. It is
now ready to be mailed.

Before you begin:
Gather the unused and/or expired medicine
you wish to mail for disposal. Leave all
medicine in its original container(s).
If you wish, you may use a marker to black out
your
name
Telephone Scams and
Frauds
and personal
information on
the medicine
bottle.
However,
please do not
black out the
name and quantity of the medicine. This helps
us to identify the medicine for disposal.

P AGE 3

S AFE M EDICINE D ISPOSAL

FOR

ME

S AFE M EDICINE D ISPOSAL

FOR

ME

P AGE 4

Please leave medicine in the original
container(s). Do not black out the name of
the medicine or the number of pills.

The Food and Drug Administration (FDA) requires special handling of certain drugs to ensure safe distribution
and use. Due to these requirements, some manufacturers provide for their own disposal programs. Please
check the medicine package or contact your pharmacist for more information about manufacturer disposal
programs that may exist for the medicine you have.

Please place all medicine you wish to dispose
of into the postage-paid envelope provided.
Do not put the following items into the
envelope:
1. DO NOT place loose pills into the envelope.
Leave all pills in their original bottles. This will
help us to identify the drug for disposal. If you
need more than one envelope, please request
an additional envelope from a participating site
or call 1-866-637-9743.

2. DO NOT put syringes or sharp objects into
the envelope. No syringes, sharps, or needles
or other items that may cause
injury to the postal carrier or
program staff are to be placed
into the postage-paid envelope.
Even if these items are
packaged or wrapped, they are
not to be placed in the envelope. If you would
like more information about proper disposal of
sharps, please contact your healthcare provider
or visit: www.safeneedledisposal.org
3. No batteries, electronics, medical devices
(hearing aids, blood sugar monitors), or
thermometers should be placed into the
envelope.
No needles, loose pills, pills in baggies, broken glass, sharp objects, medical devices, or
thermometers are to go into the envelope.
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Please leave medicine in the original
container(s). Do not black out the name of
the medicine or the number of pills.

The Food and Drug Administration (FDA) requires special handling of certain drugs to ensure safe distribution
and use. Due to these requirements, some manufacturers provide for their own disposal programs. Please
check the medicine package or contact your pharmacist for more information about manufacturer disposal
programs that may exist for the medicine you have.

Please place all medicine you wish to dispose
of into the postage-paid envelope provided.
Do not put the following items into the
envelope:
1. DO NOT place loose pills into the envelope.
Leave all pills in their original bottles. This will
help us to identify the drug for disposal. If you
need more than one envelope, please request
an additional envelope from a participating site
or call 1-866-637-9743.

2. DO NOT put syringes or sharp objects into
the envelope. No syringes, sharps, or needles
or other items that may cause
injury to the postal carrier or
program staff are to be placed
into the postage-paid envelope.
Even if these items are
packaged or wrapped, they are
not to be placed in the envelope. If you would
like more information about proper disposal of
sharps, please contact your healthcare provider
or visit: www.safeneedledisposal.org
3. No batteries, electronics, medical devices
(hearing aids, blood sugar monitors), or
thermometers should be placed into the
envelope.
No needles, loose pills, pills in baggies, broken glass, sharp objects, medical devices, or
thermometers are to go into the envelope.

P AGE 5
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Where will my medicine go?
All medicine that you place in the pre-paid
envelope provided will be sent to the Maine Drug
Enforcement Agency for proper disposal.
How much does this cost?
Only a total of 4 oz (or 120ml) of liquids, gels,
and creams total can be mailed back. Wrap
them in paper towels, place them in a zip lock
bag, and put it in the envelope. Be sure to seal
the zip lock bag and envelope tightly.

There is no cost to you to participate. Postage
and disposal costs have been paid through
support from the Maine Drug Enforcement
Agency and other in-kind donations from
program partners.

Instructions
Liquids, Gels, and Creams
The total combined volume of all liquids, gels,
and creams returned should be 4 ounces
(about 120 ml) or less. Please wrap each
container of liquid, gel, or cream in a paper
towel and place it in a zip-lock bag before
placing them in the envelope with any other
medicine.
Once all your medicine is placed in the
postage-paid envelope, complete the survey
provided. Place your
completed survey in the
envelope and seal it. It is
now ready to be mailed.

Before you begin:
Gather the unused and/or expired medicine
you wish to mail for disposal. Leave all
medicine in its original container(s).
If you wish, you may use a marker to black out
your
name
Telephone Scams and
Frauds
and personal
information on
the medicine
bottle.
However,
please do not
black out the
name and quantity of the medicine. This helps
us to identify the medicine for disposal.
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ME

S AFE M EDICINE D ISPOSAL

The Safe Medicine Disposal for
ME Program

ME

P AGE 6

Complete the survey
and place it in the
envelope with your
medicine.

Safe Medicine Disposal for ME is administered by the University of Maine Center on Aging
and Safe Medicine for Maine in partnership with
the Maine Drug Enforcement Agency, the Maine
Department of Environmental Protection, the
United States Postal Service, and many other organizations concerned about protecting the
health and welfare of Maine’s citizens. Because
our program partners are committed to your
health and safety, you are invited to take part in
this exciting new program. The program was created to give Maine residents a safe disposal option for unused and unwanted medicine.

FOR

If you have questions about what to put
into the envelope, please call the
Program Helpline at: 1-866-ME-RX-RID (1-866637-9743).
Visit our website: www.SafeMedDisposal.com
E-Mail: info@SafeMedDisposal.com

By mailing back your unused medicines, you:
⇒

Reduce your risk of taking medicine in error
that may be harmful or cause interactions with
other medicine

⇒

Reduce wasted healthcare dollars by
contributing to important research

⇒

Dispose of your medicine in a way that
protects Maine’s environment and prevents
groundwater contamination

⇒

Get unwanted medicine out of your home and
away from people who may want to steal your
medicine or take it illegally

Find the 5-digit code
number in the bottom left
hand corner of your
envelope.

Write it here and
keep for your records:__ __ __ __ __

•

Hand the envelope directly to your mail carrier,

•

Bring it directly to your local Post Office for
mailing,

•

Place the envelope into a blue United States
Postal Service mailbox at your local Post
Office or other locations in your area, or

•

Place the envelope in your home mailbox.

Thank you for participating in this program! If you
have any further questions or comments about
the program please call:

1-866-637-9743
Please keep this booklet for your records.

Turn to view

Thank you for participating!
For more information:
Call: 1-866-637-9743
Visit: www.safemeddisposal.com

There are several choices available to you
including:

5

Mail the envelope as you would any other letter
or package through the U.S. Mail.

4

Mailing Your Envelope

Seal envelope and mail it. No postage is needed. Mail the postage-paid
envelope as you would any other letter or package through the U.S. Mail.

ME

Make a note of your envelope code number. It is a four
digit number located in the bottom left hand corner of
your envelope.
Write it here:__ __ __ __

FOR

3

S AFE M EDICINE D ISPOSAL

Complete the enclosed survey and place it in the envelope with
your medicine. DO NOT WRITE YOUR NAME ON THE
SURVEY OR PROGRAM ENVELOPE

P AGE 7

Turn to view

2

1

Steps

9
No sharp objects or needles
9
No batteries, electronics, or medical devices (hearing
aids, blood sugar monitors)
9
No thermometers
9
Leave all medicine in the bottle/packaging
9
Containers with liquids, gels, or creams are to be wrapped in a
paper towel and sealed in a zip lock bag before you put them in the
envelope. Only 4 ounces (or 120 ml) total of liquids, gels or creams can be
mailed.

Place your unused medicine into the postage-paid envelope.

5 Step Quick Instruction Guide
Read through this booklet for information on the Safe Medicine
Disposal for ME Program.
**Keep this booklet. Do not mail it with your medicine.**
If you have questions, please call our Helpline: 1-866-637-9743

Safe Medicine Disposal for ME Program

S AFE M EDICINE D ISPOSAL
FOR

ME
P AGE 8

Program Partners

The program has been made possible by the
following organizational partners:

Please see back page for full listing of program partners

Partners for this program include the:
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦
♦

University of Maine Center on Aging
U.S. Environmental Protection Agency
U.S. Postal Service
Community Medical Foundation for Patient Safety
Safe Medicine for Maine
Maine Department of Environmental Protection
Maine Drug Enforcement Agency
U.S. Drug Enforcement Administration
Rite Aid Pharmacies
CVS Pharmacies
Maine Office of Elder Services
Maine Office of Substance Abuse
Maine Association of Psychiatric Physicians
Maine Office of the Attorney General
Maine Pharmacy Association
Maine RSVP Programs
Margaret Chase Smith Policy Center
Maine Medical Association
Maine Office of Adult Mental Health
Miller Drug
National Council on Patient Information and Education
Northern New England Poison Center
Villanova University Center for the Environment
Maine Department of Health and Human Services
Maine Council for Child and Adolescent Psychiatry
Community organizations and pharmacies throughout
Maine

Edition: September 2, 2009
© 2009 University of Maine Center on Aging
Instructional photographs: © 2007 Liv Kristin Robinson
Funded through a Fund for Healthy Maine allocation to the Maine Drug
Enforcement Agency

Safe Medicine
Disposal for ME
Program
A program for all Maine
residents!
INSTRUCTION BOOKLET
Information on how to
prepare and return your
medicine for proper disposal
Helpline: 1-866-637-9743

Please Read
Survey Instructions and Informed Consent
Safe Medicine Disposal for ME Program
As a Maine resident, you are being given the opportunity to safely and properly dispose
of your unused medicine at no cost. As a participant taking advantage of this service,
you are offered the opportunity to tell us more about the medicine you are returning and
the reason for disposal. The University of Maine Center on Aging and Safe Medicine
for Maine has received funds from the Maine Drug Enforcement Agency to offer this
medicine return program. We will be studying the types of unused medicines Maine
residents are interested in disposing.
As a medicine return program participant, you are invited to take part in this important
research currently being done throughout Maine. Information collected from the survey
provided will also tell us more about the reasons for disposal and the types of medicines
that are piling up in homes across the state. Research findings will help us to design
more medicine disposal opportunities for Maine residents and for use nationally.
If you would like to contribute to this research, please take a moment to complete the
enclosed survey.
What will you be asked to do?
If you decide to participate in the research, you will be asked to complete the enclosed
survey. It will take approximately 10-15 minutes to complete this survey. Please return
the survey in the pre-paid envelope provided along with the medicines you are
returning. You may skip any questions you do not want to answer.
Risks of participating in the survey
Except for your time and inconvenience, participation presents no more risk than you
would normally experience throughout the course of your day.
Benefits of participating in the survey
There is no immediate benefit to you for taking the survey.
Confidentiality
This survey is anonymous. The information you provide on your survey will be kept
private. Only the Center on Aging staff and staff from the Maine Drug Enforcement
Agency (MDEA) will have access to your returned survey. Please do not write your
name on your survey. Surveys will be collected from the returned envelopes once they
are opened for inventory at the MDEA. After the envelopes are opened, all surveys will
be kept at the Center on Aging for secure storage and reporting.
We will not collect personal information from returned medicine bottles (name,
physician, etc.). If you wish to black out your name and personal information on the
medicine bottle, be sure to leave the medicine name and quantity visible. This will help
us identify the medicine for research and disposal. Information you provide on the
survey will be linked to information on the type and amount of medicine you returned.
At the conclusion of the study, medicine and containers will be destroyed. All returned
medicine will be destroyed in an environmentally friendly way by the Maine Drug
Enforcement Agency.
-Please Turn Over-
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Any quotes or information used in reports and papers about this research will not
be linked to your personal information. The survey you provide us will be kept
indefinitely by the Center on Aging.
Voluntary
Your participation in this research is voluntary. You may choose to participate or not
participate. You may skip any questions you do not wish to answer. You do not need to
fill out a survey in order to return medicine.
Along with this information sheet you will find the survey that we are asking you to
complete. Completing the survey and returning it in the envelope provided along with
the medicine you are returning will let us know that you want to be a part of this
research.
Contact Information
If you have questions about the program or how to use the envelope, please call 1-866637-9743.
If you have questions about the survey and research you may reach the Project’s
Principal Investigator, Dr. Lenard Kaye, at 207-262-7922 or len.kaye@umit.maine.edu.
If you have any questions about your rights as a research participant, please contact
Gayle Anderson, Assistant to the University of Maine’s Protection of Human Subjects
Review Board, at 207-581-1498 or e-mail gayle.anderson@umit.maine.edu.
Thank you!

Page 2

DO NOT write your name (or the name of the person for whom you are returning medicine)
anywhere on this form.

Safe Medicine Disposal for ME Program Survey

INSTRUCTIONS:
1. Before completing this survey, please read through the survey instructions
provided to you with your envelope.
2. This form is for research purposes only. Research findings will help us to design
more medicine disposal opportunities for Maine residents and create a national
model.
3. You do not need to complete this survey in order to return your medicines. If you
choose to take the survey, please return it in the same pre-paid envelope given to
you to return your medicine.
NOTE: If you need help filling out this form, please call: 1-866-637-9743
Please check the appropriate boxes or write in the spaces provided. You may skip
any questions you do not want to answer.

1.
Have you returned medicine using this mailback program before?
(Please check (9) one)
Yes

No, this is my first time returning medicine using this program.

Your age: __________years
2.

The medicine(s) I am disposing is: (Please check (9) all that apply)
My own medicine
A relative’s medicine
A deceased friend or relative’s medicine
A friend’s medicine
Pet/Veterinary medicine
I don’t know whose medicine it is

For the questions below, please tell us about yourself and the medicine you are
returning. If you are returning medicine for someone else or for more than one
person, please tell us about the person for whom most of the medicine was
prescribed.
3.

Home zip code: ___________

4.

Gender:

5.

Age: _________years

6.

Are there any people living in the household in the following age
groups? (Please check (9) all that apply)

Male

Female

Newborn to 10 years
11 to 20 years
21-64 years
65+ years

-Please Turn Over-
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DO NOT write your name (or the name of the person for whom you are returning medicine)
anywhere on this form.

7.

How did you normally dispose of your unused and unwanted medicine
before today? (Please check the method you used most often)
Flush down the toilet
Put in trash
Bring to a drug collection event or give to law enforcement officer
Don’t know
Other:___________________________

8.

Where did you get these medicines? (Please check (9) all that apply)
Sample given to me at the doctor’s office
Local pharmacy
Internet pharmacy
Mail order pharmacy
Given to me by a friend or family member
Other (please list):___________________________

9.

Why do you want to get rid of these medicines? (Please check (9) all
that apply)
Doctor told me to stop taking the medicine(s)
Doctor gave me new medicine(s) to take instead
I had a reaction or allergy to the medicine(s)
I did not like the side effects
I did not want to take it
I got better/did not need it any more
I don’t want anyone else to use them
Other (please list):_______________________________________
I don’t know/I don’t remember

10.

What is the most important reason behind your decision to use this
program?
Please place only one check by the most important reason to you.
a) Best for the environment
___
b) Safest for me and my family
___
c) Other: __________________________________________

11.

How important are the following features of this program?
Please rank from 1-3 with 1 being the most important and 3 being the least
important.
a)
b)
c)
d)

12.

Convenient to use
___
Free to use
___
Anonymous
___
Other: __________________________________________

___

How useful is this medicine mail-back disposal program to you? (please
circle)
Very useful

13.

___

Useful

Somewhat useful

Not useful

What can we do to improve this program? (please write in)

+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
When complete, please fold the survey and place it into the envelope along with the
medicines you are mailing back. For more information about the Safe Medicine Disposal
for ME Program please visit: www.safemeddisposal.com, e-mail:
info@safemeddisposal.com or call 1-866-ME-RX-RID (1-866-637-9743). Thank you.
©2009 University of Maine Center on Aging
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APPENDIX GROUP 8
Consumer and Community Education Items
•

APPENDIX GROUP 8: Consumer and Community Education Presentation
Materials
o APPENDIX 8A: Sign-in sheet for community presentations
o APPENDIX 8B: PowerPoint presentation
o APPENDIX 8C: Program information handout
o APPENDIX 8D: Community presentation evaluation form
o APPENDIX 8E: Guidelines for community volunteers
o APPENDIX 8F: Self-report timesheet for community volunteers
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Sign in Sheet

Safe Medicine Disposal for ME
Community Education Presentation
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9
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19
20

Thursday, October 16, 2008

Rockland

Print Name

County of Residence Age

Funded by the U.S. EPA (Grant #CH-83336001-0)

A way for Maine’s citizens to safely and properly get rid of unused or
expired medicine

***

SAFE MEDICINE
DISPOSAL FOR ME

is a way for Maine’s citizens to
safely and properly get rid of
unused or expired medicine

Safe Medicine Disposal for ME

Introduction

Postage-paid envelopes are taken
home to mail back unused and
expired medicine
An Instruction Booklet, Survey, and
Survey Instructions are included in
each envelope
If participants need help, they can
call the Program Helpline at
1-866-637-9743

Overview of Program

•Envelopes received, logged,
catalogued and destroyed
under MDEA custody

•Secure delivery to Maine
Drug Enforcement Agency

•Program Participants

Program Model

• Remove unneeded prescription drugs
from circulation
• Disposal in compliance with applicable
state and federal laws and sound
environmental practices

Program Goals

Please take this
time to complete
the first page of the
evaluation form.

Test your knowledge about
Safe Medicine Disposal

• Medication Safety

• Teen Prescription Drug Abuse in
Maine

• The Environmental Impact of
Pharmaceuticals

Focus Areas

In a recent study by the
Maine Dept of Environmental
Protection (DEP),
Pharmaceuticals and
Personal Care Products
(PPCPs) were found in 18
out of 19 samples with a
majority of sites having 3 or
more types of PPCP present.

Environmental Impact
of Pharmaceuticals

• In every metropolitan area where the public
drinking water has been tested, trace amounts of
pharmaceuticals have been found.

•Pharmaceutical drugs are present both from human
waste and from intentional flushing of prescription
drugs in the toilet.

Facts from across the U.S.:

Environmental Impact
of Pharmaceuticals

•These drugs are finding their way into
drinking water and are being ingested by
humans wildlife, and fish

•Waste water treatment facilities are not
equipped at this time to deal with
screening for these drugs or removing
them from the water

•The federal government currently does
not have regulations or standards in
place to control pharmaceuticals found in
drinking water.

Impact on us:

Environmental Impact
of Pharmaceuticals

•Participate in the Safe Medication Disposal
for ME program by calling 1-866-637-9743.

• Do not keep medications stockpiled in your
home and keep careful track of your
prescriptions.

•Utilize local prescription mail-back or
collection programs to dispose of your
unused/unwanted medications.

What Can You Do?

Environmental Impact
of Pharmaceuticals

According to results taken from the 2006 Maine
Youth Drug and Alcohol Use Survey, an average
of 12% of teenagers from grade six through 12
across the state reported experimenting with
prescription drugs.

Youth prescription drug abuse is a problem in
Maine. About 1 in 5 Maine youth grades 9-12
report having used a prescription drug not
prescribed to them to get high. Non-medical use
of prescription drugs is the second most popular
category of drug abuse after marijuana.

•

•

Teen Prescription Drug Abuse in
Maine

•

•

•

Nearly one in five teens report abusing
prescription medications to get high.
Teens are misusing everything from pain
relievers to stimulants, sedatives and
tranquilizers.
Many teens believe that prescription drugs
are safer than alcohol or illicit drugs, and
that abusing them isn’t risky.

Facts About Teens and
RX Abuse

• One of the fastest growing
trends with teenage prescription
drug abuse is the Pharm Party.
These are parties where each
person brings bottles of
prescription medications that
they can find to a party where
the medications are then put
into a punch bowl for
everybody to take like candy.
Other names for this are
“skittling” and “fish bowling”.

“Pharm” Parties

Fact – Abusing certain prescription painkillers is similar to
abusing heroin.

Myth – Prescription painkillers, even if they are not prescribed
by a doctor, are not addictive.

Myths & Facts

Fact – Taking prescription medicine that your doctor didn’t
prescribe and doesn’t know about can result in a
dangerous situation if he or she actually prescribes
medicine for you that should not be mixed with what
you are abusing “on the sly”.

Myth – There is nothing wrong with using prescription drugs
without a doctor’s consent.

Myths & Facts

Fact – Prescription drugs are safe when used correctly under
a doctor’s supervision. But taking prescription drugs
that aren’t intended for you and/or mixing them with
alcohol or illicit drugs can result in potentially deadly
consequences.

Myths – If a prescription drug is legal and widely available, it
must be safe.

Myths & Facts

Dispose of any unused
or unwanted medications
properly.
Keep close track of your
prescription medications
in case any go missing
or are refilled without
your knowledge.

•

•

Ways You Can Help:

•

•

Avoid stockpiling
prescription
medications in your
home and keep them in
a safe place.
Encourage talking with
your pre-teen/teenage
relatives about the
risks of abusing
prescription
medications

Ways You Can Help

•

•

Over 40% of poisoning reported to the poison control
center are from mishandling or misuse of prescription
drugs.
Those who abuse prescription drugs often meet their
own needs by stealing drugs or stealing property in
order to buy drugs.

Reasons why keeping unused or expired
drugs in your home is not safe:

Medication Safety

If medications are burned, they can release
pollutants into the air

If they are thrown out, they can be
scavenged and sold illegally

If medications are flushed, they can have
damaging effects on the environment

•

•

•

Disadvantages of some methods of disposal:

Medication Safety

•Store medicine safely, out of the reach of children
and in a locked cabinet if possible

•Check expiration dates on your prescription and nonprescription medication

•Review the contents of your medicine cabinet
regularly

Remember to:

• Contact Maine Poison Control Center at
1-800-222-1222

• Contact your local law enforcement office to
see if they sponsor a medication take-back
event or drug drop off day

• Utilize the Safe Medicine Disposal for ME
Program

How Can you Safely
Dispose of Medications

Thank you!

Please feel free to ask questions
at this time, and kindly
complete page two of the
evaluation form.

Evaluation & Questions

•

•

•

•

•

Donn, J., Mendoza, M. and Pritchard, J. (2008, March 10). Drugs found
in drinking water. USA Today. Retrieved from
http://www.usatoday.com/news/nation/2008-03-10-drugs-tapwater_N.htm
Maine Office of Substance Abuse. (2004). The cost of alcohol and
drug abuse in Maine 2000 executive summary. Retrieved from
www.maine.gov/dhhs/osa/pubs/data/2004/costsummary04.pdf
Maine Safe and Drug-Free Schools and Communities Act Program.
(2006-2007). Report on incident of prohibited behavior and drug and
violence prevention. Retrieved from
www.mainesdfsca.org/pdf.lobster0607.pdf
Project AWARE. (unknown). Parents: Are you aware? Retrieved from
www.projectaware.net/pdf/pa_parents.pdf retrieved August 8, 2008.
National Institute on Drug Abuse. (2008). Prescription Medications.
Retrieved August 8, 2008, from
http://www.drugabuse.gov/drugpages/prescription.html

Source Citations

info@safemeddisposal.com

Or you can email:

1-866-637-9743

• Please feel free to call the project hotline for
additional information or with any questions
at:

Safe Medicine for ME

The envelope will contain:
• An Instruction Booklet explaining how to prepare
and mail unwanted medicine
• A Survey to be filled out and returned with the
medicine
• Survey Instructions and an Informed Consent for
completing the Survey

At participating pharmacies, participants
will find a postage-paid envelope for
disposal of unwanted medicine

Mailing Instructions

• Program envelopes are
not appropriate for
institutions, group
homes, or assisted living
facilities to use for
disposal of group
medicine collections

•• The program envelopes
are for individual or
family use only

Envelopes are for individual
safe medicine return only!

• Participants collect unwanted medicine from
their home
• They leave medicine in the original bottles
(if possible) and put the bottles in the
envelope according to the instructions
• Participants also fill out a survey and put it in
the envelope

What goes into the
envelope?

• The Maine Drug
Enforcement Agency
receives the envelopes
with the medicine
• The medicine is
cataloged by project
pharmacists and safely
destroyed

What happens to the
medicine?

• After participants have mailed the
envelope, they will need to call the
Program Helpline at 1-866-637-9743 and
leave a message with the envelope code
number and date they mailed the
envelope

Calling the Program Helpline
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¾
¾

¾
¾

¾
¾

¾
¾

¾

¾

¾

¾

¾
¾

Center on Aging, University of Maine
Maine Association of Psychiatric Physicians
Maine Benzodiazepine Study Group
(MBSG) & Drug Disposal Group
Maine Council for Child & Adolescent
Psychiatry
Maine Department of Health and Human
Services
Maine Department of Environmental
Protection
Maine Drug Enforcement Agency
Maine Office of Adult Mental Health
Services
Maine Office of Substance Abuse
Maine Center for Disease Control and
Prevention
Maine Office of the Attorney General
Maine Office of Elder Services
Maine Pharmacy Association
Maine Independent Pharmacies
Maine RSVP Programs

Maine-Based Organizations

¾
¾

¾
¾

¾
¾

¾

¾
¾

¾

¾

American Pharmacists Association
Community Medical Foundation for Patient
Safety
National Council on Patient Information and
Education
Office of the U.S. Attorney General
Rite Aid Corporation
U.S. Drug Enforcement Administration
U.S. Environmental Protection Agency
U.S. Postal Service
Villanova University Center for the
Environment

Federal & National Organizations

Margaret Chase Smith Center Policy Center,
University of Maine
Northern New England Poison Center

Program Partners and National
Advisory Board

Safe Medicine Disposal for ME:
Funded by the U.S. EPA Aging Initiative
Program goals:
• Remove unneeded prescription drugs from circulation by providing an
environmentally safe way to dispose of medications.
Environmental impact of pharmaceuticals:
Studies are revealing negative environmental impacts on water quality and aquatic life from
flushed medications.

•

Facts about Teens and Rx Abuse:
Many teens believe that prescription drugs are safer than alcohol or illicit drugs, and that
abusing them isn’t risky.
• “Pharm Parties” are where teens dump bottles of prescription medications into a punch bowl
and ingest random medications to get “high”.

•

Medication Safety:
• Some poisonings reported to poison control centers come from the accidental ingestion of
medications that have been left unsupervised and within the reach of children.
• Home burglaries related to prescription drugs are on the rise.
Remember to:
• Review the contents of your medication cabinet regularly.
• Check the expiration dates on your prescription and nonprescription medications.
• Store medications safely, out of the reach of children and in a locked cabinet if possible.
How you can safely dispose of medications:
• Utilize the Safe Medicine Disposal for ME program. Call the program helpline at
1-866-637-9743 for more information. Or email: info@safemeddisposal.com.
• Contact your local law enforcement office to see if they sponsor a medication take-back
event or drug drop-off day in your community.
• Contact the Northern New England Poison Control Center at 1-800-222-1222 for other safe
disposal options and to add medication take-back event dates to their
informational calendar.
Information gathered with thanks from:
National Council for Patient Information and Education
U.S. Environmental Protection Agency
Northern New England Poison Control Center
Maine Department of Environmental Protection
Maine Office of Substance Abuse Services
Maine Benzodiazepine Study Group
Project AWARE

Safe Medicine Disposal for ME Community Education
Presentation
Instructions: This survey form was developed to find out levels of awareness that the general public has
of prescription medication issues. Each audience member can complete the questionnaire. The
information collected by the evaluation helps to improve these types of community education programs.
1. Today’s Date: _____/______/_________ (MO/DD/YYYY)
2. What county was this presentation provided in?: (please fill in the blank below)
__________________________________________________________________
3. Your Age:
_____19 or under
_____50-59

_____20-29
_____60-69

_____30-39
_____70-79

4. Your gender:

_____Male

_____Female

_____40-49
_____80 and over

5. Have you ever participated in a community take back/drug drop off program to dispose of unwanted
medications?
(Please circle one)
YES NO
6. Overall, how would you rate this presentation: (circle one)
Needs Improvement
OK
Good

Excellent

7. Comments:____________________________________________________________________
Respond to each of the following statements below by circling either TRUE or FALSE in the box next to
the statement.
1. It is important to discard any unused or
TRUE
FALSE
expired medications in my home.
2. It is important to discuss the dangers of
TRUE
FALSE
prescription medications with family
members.
3. Proper disposal of medications protects the
TRUE
FALSE
environment and keeps people safe.
4. Prescription painkillers are not addictive
TRUE
FALSE
because doctors prescribe them.
5. Prescription drug abuse is not a problem in
TRUE
FALSE
Maine.
6. Many teens believe that prescription drugs
TRUE
FALSE
are safer than alcohol or illicit drugs, and
that abusing them is not risky.
7. Flushing medications does not harm the
TRUE
FALSE
environment.
8. Medicine has an expiration date similar to
TRUE
FALSE
food that you should pay attention to.

Thank you! Please give this sheet to your presenter before you leave.

Presentation Guidelines for “Safe Medicine Disposal for ME” Volunteer
Community Education Presentations
Setting up a speaking event:
1. Arrange speaking opportunity with a community group – inform Jen
about date, time, place, and audience size
2. Ideal audience size is 10-15 people
3. Plan on a total meeting time of 30 minutes (allowing time for discussion)
4. Use a round-table approach if possible
5. Distribute the handouts/pamphlets to audience members before you start
6. Go through the presentation slides with the audience – demonstrate the
use of the envelopes at the end of the presentation
7. Have audience members fill out an evaluation form and pass them in to
you before they leave – in exchange they will receive an envelope
8. If possible, take pictures at the event
Materials checklist:
1. Copy of the presentation for you to speak from
2. Sign-in sheet
3. Educational pamphlets/handouts
4. Evaluation forms
5. Drug return envelopes
6. Pens
7. Camera (you supply)
8. “Safe Medicine Disposal for ME” name badge (previously given)
Presentation flow:
1. Introduce yourself as a “Safe Medicine Disposal for ME” volunteer
2. Have the audience members fill out the sign-in sheet
3. Inform audience members that your goal is to provide them with
information about medication safety and the “Safe Medicine Disposal for
ME” program
4. Distribute educational materials and the evaluation form to the audience
and begin the presentation by following the presentation outline
5. At the end, demonstrate how to use the drug return envelopes
6. Have audience members fill out evaluation forms and in exchange for a
completed evaluation they will receive an envelope
7. Thank them for their participation

RSVP
Safe Medicine Disposal for ME Program

RSVP VOLUNTEER HOURS
Self-Reporting Timesheet
COMMUNITY VOLUNTEERS
Name
Address

_________________________________________________________
_________________________________________________________
_________________________________________________________

To be completed by the RSVP Volunteer:
Volunteer Activity/Location

Hours

Date

__________________________________________

____________

__________

__________________________________________

____________

__________

__________________________________________

____________

__________

__________________________________________

____________

__________

__________________________________________

____________

__________

__________________________________________

____________

__________

__________________________________________

____________

__________

__________________________________________

____________

__________

__________________________________________

____________

__________

Total
Hours ____________
Volunteer Signature ________________________________________________
Signature of On-Site Contact Person____________________________________
Please return at the end of the month to:
UMaine Center on Aging
RSVP
Camden Hall
25 Texas Avenue
Bangor, Maine 04401-4324

APPENDIX GROUP 9
Marketing & Outreach Items
•

APPENDIX GROUP 9: Marketing and Outreach Materials
o APPENDIX 9A: Consumer fact sheet
o APPENDIX 9B: Detailed fact sheet
o APPENDIX 9C: Program brochure
o APPENDIX 9D: Program summary sheet
o APPENDIX 9E: Program business cards
o APPENDIX 9F: April 2007 program press release
o APPENDIX 9G: July 2009 program press release
o APPENDIX 9H: Sample press release for local communities
o APPENDIX 9I: Save the date announcement for the 2008
International Symposium on Pharmaceuticals in the Home and
Environment
o APPENDIX 9J: Save the date announcement for the 2009
International Conference on Safe Medicine
o APPENDIX 9K: List of program-related publications and
presentations
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CONSUMER FACT SHEET

Safe Medicine Disposal for ME Program
Do you have unwanted or expired
prescription medicine in your home?
Many people do not use all of the medicine they were
prescribed. It is important to get rid of your unwanted or expired
medicine safely.
This can help prevent:
• Accidental poisoning of children, grandchildren, and pets
• Intentional misuse by teenagers and adults-even people you know
• Health problems from taking the wrong medicine, too much of the same
medicine, or a medicine that is too old to work well
• Theft of the medicine by drug users who may break into your home
You can get rid of your unwanted or expired medicine in a
way that keeps people safe and helps keep leftover
prescription medicine from getting into Maine’s water supply
and environment.
Some options include:
• A medicine disposal program by mail, like Safe Medicine Disposal for ME. This
program provides Maine residents of all ages with a special envelope to mail
unwanted or expired prescription medicine for safe disposal.
•

A community medicine drop-off event. You can find out if
there is a program in your area by contacting Northern
New England Poison Center at 1-800-222-1222. You can
also call them to get help identifying your medicine or for
medicine-related concerns.

•

Talking to your pharmacist or local law enforcement about other safe options
For more information about safe medicine disposal, contact:
Safe Medicine Disposal for ME
1-866-ME-RX-RID
(1-866-637-9743)
info@safemeddisposal.com
www.safemeddisposal.com

DETAILED FACT SHEET

Safe Medicine Disposal for ME Program
Based on figures from the National Unused and Expired Medicine Registry, as many
as 40% of prescription medicines are never used. Such medicines represent an
expensive waste of healthcare resources and a potential environmental and safety
hazard.
Unused Prescription Medicine is:
An Environmental and Health Hazard
•
•
•
•

Over half of Americans dispose of unwanted prescription medicine in the trash, one-third put it down
the sink or toilet, and only 1.4% return it to a collection facility.1
Prescription medicine then enters the water through disposal down a drain or from the leaching or
leaking of the drugs from landfills.2
Over 80 pharmaceuticals of various prescription drug classes have been found in treated sewage,
surface water, and ground water throughout the country.3
Studies have found that exposure to medicine in water has been linked to serious reproductive side
effects in fish, and the full effect on humans is currently unknown.4

A Danger to Children and Pets
•
•
•

Children and pets can accidentally get poisoned by unused prescription medicine found in the home.
In the US, medicine in the home accounts for more accidental poisonings than any other product.5
Nearly 2% of children ages 12-13 intentionally misuse prescription medicine.6 Accessibility to the
medicine is likely a contributing factor to this growing trend.7

A Danger to Older Adults
•
•

Older adults make up only 13% of the population, but fill one-third of all prescriptions. This makes
them susceptible to intentional or accidental medicine misuse, dependence, and addiction.8
Diversion and theft of prescription medicine is currently at very high levels, and older adults may be
particularly at risk.9

A Danger to Communities
•
•
•

In 2002 in Maine, almost 90% of all drug deaths were caused by prescription medicine.10
The non-medical use of prescription medicine, among US residents ages 12 and older, is more
common than the use of any illicit drug except marijuana.11
Maine DEA arrests for prescription medicine misuse have increased dramatically to 16% of all
arrests.12

A Waste of Valuable Healthcare Dollars
•
•

One small study conservatively estimates the cost of wasted prescription medicine by adults ages 65
and older to be over one billion dollars annually. 13
With healthcare costs rising at 3 times the rate of inflation, this waste will only continue to grow.14

For more information contact Safe Medicine Disposal for ME

1-866-637-9743

References:
Introduction paragraph: Mireles, M. (2008). National Unused and Expired Medicine Registry. Unpublished data. Bellaire,
Texas: Community Medical Foundation for Patient Safety.
1. Bound, J. & Voulvoulis, N. (2005). Household disposal of phamaceuticals as a pathway for aquatic contamination in
the United Kingdom. Environmental Health Perspectives (electronic version), 113(12), 1705-1711.
2. Northwest Product Stewardship Council. (2006). Pharmaceuticals and product stewardship. Retrieved from
www.productstewardship.net/productsPharmaceuticals.html on 9/12/2006.
3. Heberer, T. (2002). Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of
recent research data. Toxicology Letters, 131, 5-17.
4. Disposal of unused medicines- Concern grows over environmental impacts. (2004). Journal of Environmental Health,
66(10), 42.
5. Northwest Product Stewardship Council. (2006). Pharmaceuticals and product stewardship. Retrieved from
www.productstewardship.net/productsPharmaceuticals.html on 9/12/2006.
6. National Institute on Drug Abuse (2006). Trends in prescription drug abuse. Research Report Series. Prescription
Drugs: Abuse and Addiction. Retrieved from http://www.drugabuse.gov/ResearchReports/Prescription/
prescription5.html#Older on 3/9/2007.
7. National Institute on Drug Abuse (2005).Prescription drugs. NIDA Community Dug Alert Bulletin. Retrieved from http://
www.drugabuse.gov/PrescripAlert/ on 3/9/2007.
8. National Institute on Drug Abuse (2006). Trends in prescription drug abuse. Research Report Series. Prescription
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prescription5.html#Older on 3/9/2007.
9. U. S. Drug Enforcement Administration (2006). Pharmaceutical Drugs. Retrieved from http://www.usdoj.gov/dea/
concern/18862/pharm.htm on 3/9/2007.
10. Department of Health and Human Services, Office of Substance Abuse (2005). Maine’s Prescription Monitoring Program. Retrieved from www.maine.gov/dhhs/osa/data/pmp on 9/18/2006.
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use and health: National findings. Rockville, MD: Office of Applied Studies, NSDUH Series H-30, DHHS Publication No.
SMA 06-4194.]
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U.S. Postal Service

Community Medical Foundation for Patient
Safety
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Northern New England Poison Center

Miller Drug

Maine Department of Health and Human
Services

Maine Association of Psychiatric Physicians

Maine Council for Child and Adolescent
Psychiatry

CVS Pharmacies

Maine Medical Association

Villanova University Center for the
Environment

Community organizations and pharmacies
throughout Maine

•

•

•

•

•

•

•

•

•

Information and Education

University of Maine Center on Aging

•

PROGRAM PARTNERS INCLUDE:

© 2009
University of Maine Center on Aging
Camden Hall, 25 Texas Ave, Bangor, Maine 04401

Funded through a Fund for Healthy Maine
allocation to the Maine Drug Enforcement Agency

or e-mail: info@safemeddisposal.com

call: 1-866-637-9743

INFORMATION:
For a complete listing of sites visit our
website at: www.safemeddisposal.com

Envelopes are now available throughout
Maine. Please check our website for
regular updates on site locations where
you can obtain an envelope as well as
upcoming special community events.

A disposal program for all
Maine residents!

M EDICINE
D ISPOSAL
FOR ME

S AFE

Donations are accepted.
Please call the program
helpline if you would like to
contribute.

Just follow the instructions,
and the envelopes are ready
to go!

Nothing! It is FREE to participate. Safe Medicine Disposal for ME has already
paid for the envelopes and
postage.

HOW MUCH DOES IT
COST?

Safe Medicine Disposal for
ME is an easy,
anonymous way
for Maine’s citizens
to safely and
properly get rid of
unused or expired
medicine.

WHAT IS SAFE
MEDICINE DISPOSAL
FOR ME?
Kits including an envelope and
instruction packet are given by
request to interested individuals
Participants follow the enclosed
instructions to place unused
medications in the envelope
Envelopes are returned by mail
to the Maine Drug Enforcement
Agency and then safely
destroyed

•

•

•

•

•

Older Adults
Children
Teenagers
Pets

Limit illegal diversion of
prescription drugs and drugrelated thefts and crimes

∗

∗

∗

∗

Minimize accidental overdoses
and poisonings of:

WHAT ARE THE BENEFITS?

Postage-paid medicine return
kits are distributed to participating sites across the state

•

HOW DOES IT WORK?

Help reduce waste in the
health care system

Prevent environmental exposure to protect Maine’s water
and wildlife

Decrease opportunities for
drug abuse

e-mail: info@safemeddisposal.com

or

call: 1-866-637-9743

www.safemeddisposal.com

For up-to-date information on program
sites in your area visit:

Envelope kits are available free of
charge while supplies last at participating sites. Program envelopes are
available at participating locations
throughout Maine.

WANT TO PARTICIPATE?

•

•

•

Safe Medicine Disposal for ME Program

The University of Maine Center on Aging has received funding through a Fund for Healthy Maine
allocation from the Maine Drug Enforcement Agency to operate Maine’s prescription drug-return-by-mail
program, the first of its kind in the country.
Program Take-Back Model at a glance:

→
Kits distributed to Maine
residents through
designated pharmacy and
community sites free of
charge

Unused medications
returned by mail to a
centralized Maine Drug
Enforcement Agency
location

→
Medication returns
cataloged by program
pharmacists and then
destroyed by
incineration

Why Maine?


Maine has the oldest population in the nation as measured by median age. Americans age 65 and older
account for over one-third of all prescription drugs dispensed, despite making up only about 13% of
the national population.



The state of Maine has previously experienced and documented the consequences of unused drugs
remaining in circulation. In 2002, nearly 90% of all drug deaths in Maine were caused by prescription
drugs. Maine DEA arrests for prescription drug theft and misuse have increased dramatically to 16%
of all arrests in the state. Maine ranks number one in the country in terms of the relationship of
pharmaceuticals to violent crime and property crime.

What are the benefits of this model?
Many other areas of the country are considering replicating our model of drug disposal. Here’s why:


Avoids the harmful environmental impacts and health hazards of flushing or disposing of drugs via
household trash



Easy, convenient, and anonymous way of disposing of drugs



Takes advantage of the security protocols of the U.S. Postal Service mail system



Accessible to those who live in rural areas and are unable to attend event-based or on-site medicine
return programs



Drugs are returned directly to the Maine Drug Enforcement Agency so the program is able to accept
controlled substances



From a social standpoint such a program presents the opportunity to: limit drug related crimes, limit
opportunities for drug abuse, and reduce waste related to medical and insurance costs by providing a
safe alternative from stockpiling medications in consumer’s homes



The potential environmental benefits include: protecting water and soil supplies from drug
contamination and prevention of accidental poisonings of humans, pets, and wildlife

This initiative is a unique collaboration between environmental, drug enforcement, and healthcare
officials and puts the University of Maine in the forefront of innovative outreach research. Lessons
learned through this program can be used to shape state and national public policy, physician prescribing
practices, and health education outreach strategies.
Program Partners:
Program partners include the: University of Maine Center on Aging, United States Environmental
Protection Agency, United States Postal Service, Community Medical Foundation for Patient Safety, Safe
Medicine for Maine, Maine Department of Environmental Protection, Maine Drug Enforcement Agency,
U.S. Drug Enforcement Administration, Rite Aid Pharmacies, Maine Office of Elder Services, Maine
Office of Substance Abuse, Maine Association of Psychiatric Physicians, Maine Office of the Attorney
General, Maine Pharmacy Association, Maine RSVP Programs, Margaret Chase Smith Policy Center,
National Council on Patient Information and Education, Miller Drug, Maine Department of Health and
Human Services, CVS Pharmacies, Maine Office of Adult Mental Health Services, Maine Medical
Association, Northern New England Poison Center, Villanova University Center for the Environment,
Maine Council for Child and Adolescent Psychiatry, University of New England and community
organizations and pharmacies throughout Maine.
Program Contacts:

Website: www.safemeddisposal.com
E-Mail: info@safemeddiposal.com
Phone: 1-866-637-9743
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Rx Drug Mail Back Program Comes to Your Community!
Ever wondered how to dispose of expired or unused prescription medicine? Now,
thanks to the Safe Medicine Disposal for ME Program, disposing of prescription
medicine has never been safer or easier. The program provides postage-paid mailing kits
to participating pharmacies in the area. Patrons can pick up these kits and then mail their
unused medicine to the Maine Drug Enforcement Agency for proper disposal.
The Safe Medicine Disposal for ME Program, funded by the Environmental
Protection Agency and other state partners, helps to ensure that unused medicine does not
harm Maine’s waterways or wildlife and also ensures that medicine is not available for
misuse.
This free program is available at the following COUNTY NAME HERE locations
and is open to all Maine residents:
LIST SITES HERE
Simply go to one of the pharmacies on this list to get your mail back kit. Each kit comes
with instructions and postage paid mailer. If you would like more information please
contact the program by phone or email at 1-866-637-9743, info@safemeddisposal.com or
online at www.safemeddisposal.com

For Conference Information Contact:
Jason Charland, Conference Coordinator
UMaine Center on Aging

The 2008 International Symposium on
Pharmaceuticals in the Home and
Environment: Catalysts for Change

Telephone: 207.262.7928

Monday-Tuesday
November 10-11, 2008
Wyndham Hotel Portland Airport
South Portland, ME

jason.charland@umit.maine.edu

2008 SYMPOSIUM ON
PHARMACEUTICALS IN THE HOME
AND ENVIRONMENT:
CATALYSTS FOR CHANGE

Register online at:
www.mainebenzo.org

This year's conference will be the gathering place for disseminating the latest trend
data available on prescription issues including:

* Drug diversion, fraud, prevention, and abuse
* Innovative national and international prescription drug return and
disposal programs
* Medication management and prescribing
* And much, much more!
Registration fees

2 days $199 (students = $150)
1 day $119 (students = $75)

www.mainebenzo.org

Wyndham Hotel Portland Airport
363 Maine Mall Road
South Portland, ME 04106
1-800-996-3426 (1-800-WYNDHAM)
Group Code: UMaine Center on Aging
Group Room Rate: $94. + tax

Get your Continuing Education Credits before 2008 ends!
Continuing Education Details:
The University of New England is accredited by the American Osteopathic
Association and the Maine Medical Association to provide continuing medical
education for physicians.
• UNE designates this educational activity for a maximum of 11.0 Category
2A osteopathic, and 11.5 AMA PRA Category 1 CreditsTM.
• Approved for 11.5 University contact hours (1.2 CEUs) by the University of
New England.
• CEUs pending for Maine Boards of Pharmacy and Social Work Licensure
• Certificates of attendance will be provided

Conference Sponsors:

www.mainebenzo.org

SAVE THE DATE!
Sunday-Tuesday
October 18-20, 2009

2009 International Conference
on Safe Medicine
Point Lookout Resort and Conference Center
Northport, Maine

•

•

•

•
•

Meet with the leading authorities on prescription drug use,
abuse, return and disposal
Attend cutting edge educational symposia and panel
sessions
Build your skills at expert-led, pre-conference, technical
assistance workshops
Participate in lively specialized topic interest groups
Enjoy the special networking opportunities, exhibits, and
annual film festival
Call for proposals, films, and exhibitors coming soon!

For more information contact:
Maine Benzodiazepine Study
Group
& Drug Disposal Group
UMaine Center on Aging
Phone: 207-262-7922
Email: mbsg@mainebenzo.org
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Lunn, H. (June 11, 2008). Safe Medicine Disposal for ME overview. Presentation at the Healthy
and Safe Living Event for Mature Adults, Rockland, ME. (Approx 25 people in
attendance)
Dangers of unused drugs getting more attention in Maine. (2008, June 12). Portland Press
Herald. Available online at: www.pressherald.com.
Washington County Cooperative Extension Senior Companion Program. (June 12, 2008).
Safe Medicine Disposal for ME program overview and follow-up information session.
Program presentation, Washington County, Maine.
Kaye, L. W. (June 14, 2008). Safe Medicine Disposal for ME program presentation.
Presentation at the Eastern Area Agency on Aging Medicare Event, Bangor, Maine.
Kocian, L. (2008, June 15). Getting rid of what the doctor ordered: Proper disposal of unwanted
medications is daunting, costly. Boston Globe. Available online at www.globe.com.
Safe Medicine Disposal Program initiated. (June 18, 2008). Machias Valley News Observer,
page 24.
Crittenden, J. A. (June 24, 2008). Safe Medicine Disposal for ME program overview. Panel
presentation at the Oregon Drug Take Back Program Convening Meeting, Portland, OR.
Longley, C., & Payne, B. (June 27, 2008). Safe Medicine Disposal for ME program information
table and mailing list sign-up. Presentation at the Oxford County TRIAD Senior Citizen
Picnic, Oxford County, ME.
Chaitman, S. (2008, July 9). MWRD eyes study on drugs in water. Chi Town Daily News.
Available online at: www.chitowndailynews.org.

Program publications and presentations

Pg. 2

Maguire, J. (2008, August 6). Drug disposal dilemma. Lincoln County News. Available online
at: www.mainelincolncountynews.com.
Broderick, R. (September 2008). Waste not: Managing Minnesota’s hazardous medical waste is
a complicated task. Minnesota Medicine. Available online at:
www.minnesotamedicine.com.
Kaye, L. W. (September 5, 2008). Safe Medicine Disposal for ME program overview.
Presentation at the Maine Health Access Foundation Medication Stakeholder Group
Meeting, Augusta, ME.
Charland, J. (September 11, 2008). Pilot testing of the Safe Medicine Disposal for ME
community education curriculum. Presentation at the Calais Regional Hospital
Seniority Group, Calais, ME.
Kaye, L. W. (September 11, 2008). Implementation of the Safe Medicine Disposal for ME
Prescription mail-back program. Presentation at the Society for Human Ecology
Conference, Bellingham, WA.
Gressitt, S. (October 6, 2008). Safe Medicine Disposal for ME overview, policy and practice
implications. Presentation at the Maine Office of Adult Mental Health Community
Service Network # 3, Augusta, ME.
Gressitt, S. (October 9, 2008). Safe Medicine Disposal for ME overview, policy and practice
implications. Presentation at the Maine Office of Adult Mental Health Community
Service Network # 7, Biddeford, ME.
Gressitt, S., & Crittenden, J. A. (October 11, 2008). Safe Medicine Disposal for ME overview,
policy and practice implications. Presentation at the Maine Pharmacy Association
Conference, Rockland, ME.
Gressitt, S. (October 13, 2008). Safe Medicine Disposal for ME overview, policy and practice
implications. Presentation at the Maine Office of Adult Mental Health Community
Service Network # 4, Rockland, ME.
Gressitt, S. (October 14, 2008). Safe Medicine Disposal for ME overview, policy and practice
implications. Maine Office of Adult Mental Health Community Service Network # 2,
Bangor, ME.
Nathanson, B. (October 14, 2008). Safe Medicine Disposal for ME informational table. Penquis
RSVP Annual Recognition Luncheon, Bangor, ME.
Marston, H. (October 16, 2008). Safe Medicine Disposal for ME information and community
education session. Presentation at Stella Maris Apartments, Rockland, ME.

Program publications and presentations

Pg. 3

Longly, C., & Payne, B. (October 17, 2008). Safe Medicine Disposal for ME information table.
Presentation at the Oxford County TRIAD, Rumford, ME.
Davis, S. (October 20, 2008). Safe Medicine Disposal for ME program overview and
community education session. Presentation at the Bucksport Meals for ME Site,
Bucksport Senior Center, Bucksport, ME.
Gressitt, S. (October 20, 2008). Safe Medicine Disposal for ME overview, policy and practice
implications. Presentation at the Maine Office of Adult Mental Health Community
Service Network # 5, Lewiston, ME.
Gressitt, S. (October 23, 2008). Safe Medicine Disposal for ME overview, policy and practice
implications. Presentation at the Maine Office of Adult Mental Health Community
Service Network # 5, Presque Isle, ME.
Staples, B. (2008, November 3). Agencies to assist with safe medicine disposal. Village SoupWaldo County, available online at http://waldo.villagesoup.com.
Kaye, L.W., Crittenden, J. A., Gressitt, S., & McKinney, R. (November 10, 2008). EPA projects
symposium panel. Moderated by Kathy Sykes, 2008 International Symposium on
Pharmaceuticals in the Home and Environment, Portland, ME.
Nathanson, B. (November 13, 2008). Safe Medicine Disposal for ME program overview and
community education session. Presentation at the Waldo County TRIAD, Belfast, ME.
Matulis, P., & Matulis, N. (November 20, 2008). Safe Medicine Disposal for ME program
overview and community education session. Presentation at the Piscataquis Regional
YMCA, Dover-Foxcroft, ME.
Gressitt, S. (November 21, 2008). Safe Medicine Disposal for ME overview, policy and practice
implications. Presentation at the Maine Office of Adult Mental Health Community
Service Network # 6, Portland, ME.
Pistell, A. (November 21, 2008). Mailback as a drug disposal model. Presentation for the
Product Stewardship Institute, Conference Call.
Crittenden, J.A., Kaye, L.W., Charland, J.C., & Gressitt, S. (November 22, 2008). What's in your
medicine cabinet?: Preliminary data from the first year of the Safe Medicine Disposal for
ME Program. Presentation at the 61st Annual Scientific Meeting of the Gerontolgocial
Society of America, National Harbor, MD.
Burnett, P., Charland, J.C., Kaye. L. W., & Crittenden, J.A. (November 23, 2008). Engaging
older adult volunteers in high impact activities aimed at reducing pharmaceuticals in the
environment. Presentation at the 61st Annual Scientific Meeting of the Gerontolgocial
Society of America, National Harbor, MD.

Program publications and presentations

Pg. 4

Crittenden, J. A., & Kaye. L. W. (November 24, 2008). Implementing a consumer
pharmaceutical mailback program: An analysis of the Safe Medicine Disposal for ME
Program. Presentation at the 61st Annual Scientific Meeting of the Gerontolgocial
Society of America, National Harbor, MD.
National Able Network. (December 2008). Did you know?: Safe Medicine Disposal for ME.
Able Times, 1 (1), pg. 2.
Gressitt, S., Kaye, L.W., Crittenden, J. A., & Bullard, L. (December 3, 2008). Maine unused
drug disposal project. Presentation at the CDC Promising Legal Responses to the
Epidemic of Prescription Drug Overdoses in the United States, Atlanta, GA.
Gressitt, S. (December 9, 2008). Safe medicine disposal. Panel presentation at the Maine Rural
Water Association Conference, Freeport, ME.
Huang, J. (2008, December 29). Maine program offers mail-in option for unused drugs. Maine
Public Broadcasting Network. Available online at www.mpbn.net.
Richardson, J. (2008, December 29). Maine pilots eco-friendly way to dispose of drugs; Backers,
who say it will prevent abuse, want drug makers to pay the cost. Portland Press Herald.
Available online at: www.pressherald.com.
DeGrenier, L. (January 15, 2009). Safe Medicine Disposal for ME overview and community
education session. Presentation at the Bangor YMCA Caring Connections Bone Health
Group, Bangor, ME.
Lunn, H. (February 3, 2009). Safe Medicine Disposal for ME program update. Presentation at
the Knox County Community Health Coalition, Rockland, ME.
Kaye, L.W. (February 3, 2009). Environmental consciousness and reducing prescription drug
misuse through the use of a citizen mail-back program. Keynote presentation at the
Cornell University Aging and Environment Seminar, Ithaca, NY.
DeGrenier, L. (February 5, 2009) Safe Medicine Disposal for ME Program Overview and
Community Education Session. Presentation at the Bangor House, Bangor, ME.
Gressitt, S. (2009, February 5). Proper Drug Disposal. WMPG FM Talk Radio. [Radio Program].
Lunn, H. (February 24, 2009) Safe Medicine Disposal for ME program overview and
community education session. Presentation at the Rockland Methodist Retirement Home,
Rockland, ME.
DeGrenier, L. (February 25, 2009). Safe Medicine Disposal for ME program overview and
community education session. Presentation at the Bangor YMCA Breast Cancer Support
Group, Bangor, ME.

Program publications and presentations

Pg. 5

Bowen, C. T. (2009, February 27). Prescription drugs need better controls. St. Petersburg Times.
Available online at: www.tampabay.com.
Stranahan, S.Q. (2009, February 27). Drugs in our drinking water: What do we do with unused
medicines? AARP Bulletin Today. Available online at: http://bulletin.aarp.org/
DeGrenier, L. (February 28, 2009). Safe Medicine Disposal for ME program overview and
community education session. Presentation at the Eastern Maine Healthcare
Toastmasters Group, Brewer, ME.
Lunn, H. (March 5, 2009). Safe Medicine Disposal for ME community education. Presentation
at the Rockland County TRIAD, Rockland, ME.
Kaye, Lenard W. (April 14, 2009). Testimony is support of ‘An Act To Support Collection and
Proper Disposal of Unwanted Drugs’, LD 821 – item 1. 124th Maine State Legislature,
Testimony presented before the Maine State Legislature’s Committee on Health and
Human Services, Augusta, ME.
Clement, K. (Spring 2009). Maine People Working Together To Keep Maine Green. MaineLink,
Newsletter of the Maine Hospice Council.
Lunn, H. (April 23, 2009). Safe Medicine Disposal for ME Program overview and community
education session. Presentation at the Camden Senior Citizen Club, Camden, ME.
Richardson, J. (2009, April 28). Pill-disposal idea hard for drug companies to swallow. Portland
Press Herald. Available online at: www.pressherald.com.
Davis, S. (May 14, 2009). Safe Medicine Disposal for ME Program overview and community
education session. Presentation at Gardner Commons, Bucksport, ME.
Gressitt, S. (May 23, 2009). Maine unused medicine mail back pilot summary. Presentation at
the 4th International Symposium on Environment, Athens, Greece.
Lunn, H. (June 2, 2009). Safe Medicine Disposal for ME Program overview and community
education session. Presentation at the Rockland Senior Citizens Club, Rockland, ME.
Public Information Office, Maine Department of Public Safety (2009, June 18). 1,333 pounds of
drugs returned. Communicator. Available online at: www.maine.gov.
University of Maine (2009, July 13). UMaine-based drug mail-back program refunded,
expands. Press Release.
Haskell, M. (2009, July 21). Disposal plan for drugs to expand. Bangor Daily News. Available
online at: www.bangornews.com.

Program publications and presentations

Pg. 6

Kaye, L. W. (July 23, 2009). Safe Medicine Disposal for ME: Volunteer involvement.
Presentation at Cornell University, Ithaca, NY.
Safe Medicine Disposal for ME Program Feature. (2009, July 24). MaineWatch. [Maine
Television News Program].
Trenkner, T. (2009, August 17). More envelopes for unused meds. Governing. Available online
at: www.governing.com.
Gressitt, S., & Bullard, L. (September 5, 2009). Mail model and findings of novel public unused
pharmaceutical disposal program. Presentation at the 69th World Congress of Pharmacy
and Pharmaceutical Sciences, Istanbul, Turkey.
Mireles, M., Filion, L., Crittenden, J. A., Miller, R., Hillman, R., & Helms, S. (October 18,
2009). Organizing a drug collection program or event: Practical strategies and tips.
Pre-conference workshop at the 2009 International Symposium on Pharmaceuticals in
the Home and Environment, Northport, ME.
Kaye, L. W., Gressitt, S., Crittenden, J. A., & McKinney, R. (October 19-20, 2009). Safe
Medicine Disposal for ME: A project overview. Poster presentation at the 2009
International Symposium on Pharmaceuticals in the Home and Environment, Northport,
ME.
Sykes, K., Kaye, L. W., Crittenden, J. A., Gressitt, S., McKinney, R., & Hillman, R. (October 19,
2009). Safe Medicine Disposal for ME: Findings and recommendations from phases I &
II. Presentation at the 2009 International Symposium on Pharmaceuticals in the Home
and Environment, October 19, 2009, Northport, ME.
Kaye, L. W., Crittenden, J. A., Gressitt, S. (November 10, 2009). Safe disposal of
pharmaceuticals and personal care products: Current practices in the US. Presentation
at the 137th Annual Meeting of the American Public Health Association, Philadelphia,
PA.
Crittenden, J. A., Kaye, L. W, & Gresitt, S. (November 21, 2009). Prescription drug return and
disposal programming as a vehicle for older adult civic engagement. Presentation at
the 62nd Annual Scientific Meeting of the Gerontological Society of America, Atlanta,
GA.
Kaye, L. W., & Crittenden, J. A. (November 21, 2009). Examining medicine accumulation and
disposal: Drug profiles, influencing factors and policy implications for older adults.
Presentation at the 62nd Annual Scientific Meeting of the Gerontological Society of
America, Atlanta, GA.

Program publications and presentations

Pg. 7

